10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

Or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            to            

Commission File Number: 001-35568 (Healthcare Trust of America, Inc.)

Commission File Number: 333-190916 (Healthcare Trust of America Holdings, LP)

_________________________ 

HEALTHCARE TRUST OF AMERICA, INC.

HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

(Exact name of registrant as specified in its charter)

Maryland (Healthcare Trust of America, Inc.)	20-4738467
Delaware (Healthcare Trust of America Holdings, LP)	20-4738347
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

16435 N. Scottsdale Road, Suite 320

Scottsdale, Arizona 85254

(Address of principal executive offices)

(480) 998-3478

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    

Healthcare Trust of America, Inc.	x Yes	¨ No
Healthcare Trust of America Holdings, LP	x Yes	¨ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    

Healthcare Trust of America, Inc.	x Yes	¨ No
Healthcare Trust of America Holdings, LP	x Yes	¨ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Healthcare Trust of America, Inc.	Large-accelerated filer ¨	Accelerated filer x	Non-accelerated filer ¨	Smaller reporting company ¨
			(Do not check if a smaller reporting company)
Healthcare Trust of America Holdings, LP	Large-accelerated filer ¨	Accelerated filer ¨	Non-accelerated filer x	Smaller reporting company ¨
			(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   

Healthcare Trust of America, Inc.	¨ Yes	x No
Healthcare Trust of America Holdings, LP	¨ Yes	x No

As of October 31, 2013, there were 179,640,980 shares of Class A common stock and 57,268,109 sharesof Class B common stock of Healthcare Trust of America, Inc. outstanding.

Explanatory Note

This report combines the Quarterly Reports on Form 10-Q for the quarter ended September 30, 2013 of Healthcare Trust of America, Inc., a Maryland corporation, and Healthcare Trust of America Holdings, LP, a Delaware limited partnership, of which Healthcare Trust of America, Inc. is the parent and general partner. Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” “the Company” or “our Company” refer to Healthcare Trust of America, Inc. and Healthcare Trust of America Holdings, LP, collectively.

Healthcare Trust of America, Inc. (“HTA”) operates as a real estate investment trust, or REIT, and is the general partner of Healthcare Trust of America Holdings, LP (“HTALP”). As of September 30, 2013, HTA owned an approximate 98.94% partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including long term incentive plan units) in HTALP. As the sole general partner of HTALP, HTA has the full, exclusive and complete responsibility for HTALP’s day-to-day management and control.

We believe it is important to understand the few differences between HTA and HTALP in the context of how HTA and HTALP operate as an interrelated consolidated company. HTA is a REIT whose only material asset is its ownership of partnership interests in HTALP. As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP, issuing public equity from time to time and guaranteeing certain debt of HTALP. HTALP holds substantially all of the assets of the Company. HTALP conducts the operations of the business of the Company and is structured as a limited partnership with no publicly traded equity. Except for net proceeds from public equity issuances by HTA, which are generally contributed to HTALP in exchange for partnership units in HTALP, HTALP generates the capital required through HTALP’s operations, by HTALP’s direct or indirect incurrence of indebtedness or through the issuance of partnership units.

Redeemable noncontrolling interests of limited partners, stockholders’ equity and partners’ capital are the primary areas of difference between the consolidated financial statements of HTA and HTALP. Limited partner units in HTALP are accounted for as partners’ capital in HTALP’s condensed consolidated balance sheets and as noncontrolling interest reflected within equity or redeemable noncontrolling interest of limited partners reflected outside of equity in HTA’s condensed consolidated balance sheets. The differences between stockholders’ equity and partners’ capital in HTA and HTALP result from the differences in the equity issued from HTA and HTALP.

The Company believes combining the Quarterly Reports on Form 10-Q of HTA and HTALP, including the notes to the condensed consolidated financial statements, into this single report results in the following benefits:

• enhances investors’ understanding of HTA and HTALP by enabling investors to view the business as a whole in the same manner that management views and operates the business;

• eliminates duplicative disclosure and provides a more streamlined and readable presentation since a substantial portion of the disclosure in this report applies to both HTA and HTALP; and

• creates time and cost efficiencies through the preparation of one combined report instead of two separate reports.

In order to highlight the material differences between HTA and HTALP, this report includes sections that separately present and discuss areas that are materially different between HTA and HTALP, including:

• the condensed consolidated financial statements;

• certain accompanying notes to the financial statements, including Note 11 - Stockholders’ Equity and Partners’ Capital, Note 13 - Per Share Data, and Note 14 - Per Unit Data;

• funds from operations and normalized funds from operations in Item 2 of this report;

• the controls and procedures in Item 4 of this report; and

• the certifications of the Chief Executive Officer and Chief Financial Officer included as Exhibits 31 and 32 to this report.

In the sections that combine disclosure for HTA and HTALP, this report refers to actions or holdings as being actions or holdings of the Company. Although HTALP (directly or indirectly through one of its subsidiaries) is generally the entity that enters into contracts, holds assets and issues debt, management believes this presentation is appropriate for the reasons set forth above and because the business is one enterprise and the Company operates the business through HTALP.

2

HEALTHCARE TRUST OF AMERICA, INC.

HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

TABLE OF CONTENTS

		Page
PART I - FINANCIAL INFORMATION
Item 1.	Financial Statements	4
Healthcare Trust of America, Inc.
	Condensed Consolidated Balance Sheets as of September 30, 2013 and December 31, 2012 (Unaudited)	4
	Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2013 and 2012 (Unaudited)	5
	Condensed Consolidated Statements of Equity for the Nine Months Ended September 30, 2013 and 2012 (Unaudited)	6
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2013 and 2012 (Unaudited)	7
Healthcare Trust of America Holdings, LP
	Condensed Consolidated Balance Sheets as of September 30, 2013 and December 31, 2012 (Unaudited)	8
	Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2013 and 2012 (Unaudited)	9
	Condensed Consolidated Statements of Changes in Partners’ Capital for the Nine Months Ended September 30, 2013 and 2012 (Unaudited)	10
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2013 and 2012 (Unaudited)	11
Notes for Healthcare Trust of America, Inc. and Healthcare Trust of America Holdings, LP
	Notes to Condensed Consolidated Financial Statements (Unaudited)	12
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	40
Item 4.	Controls and Procedures	41
PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	42
Item 1A.	Risk Factors	42
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	42
Item 3.	Defaults Upon Senior Securities	42
Item 4.	Mine Safety Disclosures	42
Item 5.	Other Information	42
Item 6.	Exhibits	42
Signatures		43

3

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

	September 30, 2013			December 31, 2012
ASSETS
Real estate investments:
Land	$	195,115		$	183,651
Building and improvements	2,215,513			2,044,113
Lease intangibles	386,801			352,884
Property held for sale, net	21,138			—
	2,818,567			2,580,648
Accumulated depreciation and amortization	(415,615		)	(349,118		)
Real estate investments, net	2,402,952			2,231,530
Real estate notes receivable	28,520			20,000
Cash and cash equivalents	82,181			15,956
Restricted cash and escrow deposits	20,068			17,623
Receivables and other assets, net	104,996			84,970
Other intangibles, net	41,794			44,011
Non-real estate assets of property held for sale, net	1,009			—
Total assets	$	2,681,520		$	2,414,090
LIABILITIES AND EQUITY
Liabilities:
Debt, net	$	1,125,792		$	1,037,359
Accounts payable and accrued liabilities	86,795			63,443
Derivative financial instruments - interest rate swaps	3,258			9,370
Security deposits, prepaid rent and other liabilities	32,327			24,450
Intangible liabilities, net	11,262			11,309
Total liabilities	1,259,434			1,145,931
Commitments and contingencies
Redeemable noncontrolling interest of limited partners	3,375			3,564
Equity:
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding	—			—
Class A common stock, $0.01 par value; 900,000,000 and 700,000,000 shares authorized as of September 30, 2013 and December 31, 2012, respectively; 178,475,080 and 100,086,387 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	1,785			1,001
Class B common stock, $0.01 par value; 100,000,000 and 300,000,000 shares authorized as of September 30, 2013 and December 31, 2012, respectively; 57,268,109 and 114,566,254 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	573			1,146
Additional paid-in capital	2,115,596			1,885,836
Cumulative dividends in excess of earnings	(712,148		)	(633,717		)
Total stockholders’ equity	1,405,806			1,254,266
Noncontrolling interest	12,905			10,329
Total equity	1,418,711			1,264,595
Total liabilities and equity	$	2,681,520		$	2,414,090

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
Revenues:
Rental income	$	81,906		$	76,465		$	234,338		$	220,222
Interest income from real estate notes receivable and other income	635			1,067			1,874			3,683
Total revenues	82,541			77,532			236,212			223,905
Expenses:
Rental	25,774			25,744			72,235			73,038
General and administrative	5,980			5,164			18,645			16,079
Non-traded REIT	—			350			—			4,197
Acquisition-related	1,403			1,341			3,086			6,633
Depreciation and amortization	29,581			29,228			87,554			87,091
Listing	—			4,751			4,405			17,295
Total expenses	62,738			66,578			185,925			204,333
Income (loss) before other income (expense)	19,803			10,954			50,287			19,572
Other income (expense):
Interest expense:
Interest related to debt	(12,146		)	(10,172		)	(35,543		)	(30,648		)
Interest related to derivative financial instruments and net change in fair value of derivative financial instruments	(3,042		)	(3,832		)	5,125			(10,066		)
Debt extinguishment costs	—			—			—			(1,886		)
Other income (expense)	10			(24		)	28			67
Income (loss) from continuing operations	4,625			(3,074		)	19,897			(22,961		)
Income from discontinued operations	380			143			725			410
Net income (loss)	$	5,005		$	(2,931	)	$	20,622		$	(22,551	)
Net income attributable to noncontrolling interests	(182		)	(21		)	(423		)	(37		)
Net income (loss) attributable to controlling interest	$	4,823		$	(2,952	)	$	20,199		$	(22,588	)
Earnings (losses) per share attributable to controlling interest - basic:
Continuing operations	$	0.02		$	(0.01	)	$	0.09		$	(0.10	)
Discontinued operations	0.00			0.00			0.00			0.00
Net income (loss)	$	0.02		$	(0.01	)	$	0.09		$	(0.10	)
Earnings (losses) per share attributable to controlling interest - diluted:
Continuing operations	$	0.02		$	(0.01	)	$	0.09		$	(0.10	)
Discontinued operations	0.00			0.00			0.00			0.00
Net income (loss)	$	0.02		$	(0.01	)	$	0.09		$	(0.10	)
Weighted average number of shares outstanding:
Basic	232,514			218,264			225,132			225,501
Diluted	235,023			218,264			226,771			225,501
Dividends declared per common share	$	0.14		$	0.14		$	0.43		$	0.49

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(In thousands)

(Unaudited)

	Common Stock Issued						Par Value			Additional Paid-In Capital			Cumulative Dividends in Excess of Earnings			Total Stockholders’ Equity			Noncontrolling Interest			Total Equity
	Common Stock		Class A		Class B
Balance as of December 31, 2011	228,491		—		—		$	2,284		$	2,032,305		$	(467,249	)	$	1,567,340		$	—		$	1,567,340
Share-based award transactions, net	626		41		12		7			6,358			—			6,365			5,925			12,290
Issuance of common stock under the DRIP	3,362		—		—		33			31,882			—			31,915			—			31,915
Repurchase and cancellation of common stock	(3,070	)	(14,936	)	(144	)	(181		)	(185,097		)	—			(185,278		)	—			(185,278		)
Conversion	(229,409	)	57,429		171,980		—			—			—			—			—			—
Dividends	—		—		—		—			—			(111,165		)	(111,165		)	(73		)	(111,238		)
Net income (loss)	—		—		—		—			—			(22,588		)	(22,588		)	—			(22,588		)
Balance as of September 30, 2012	—		42,534		171,848		$	2,143		$	1,885,448		$	(601,002	)	$	1,286,589		$	5,852		$	1,292,441
Balance as of December 31, 2012	—		100,086		114,566		$	2,147		$	1,885,836		$	(633,717	)	$	1,254,266		$	10,329		$	1,264,595
Issuance of common stock	—		20,707		—		207			228,099			—			228,306			—			228,306
Share-based award transactions, net	—		427		(15	)	4			1,948			—			1,952			3,177			5,129
Repurchase and cancellation of common stock	—		(28	)	—		—			(287		)	—			(287		)	—			(287		)
Conversion	—		57,283		(57,283	)	—			—			—			—			—			—
Dividends	—		—		—		—			—			(98,630		)	(98,630		)	(954		)	(99,584		)
Net income (loss)	—		—		—		—			—			20,199			20,199			353			20,552
Balance as of September 30, 2013	—		178,475		57,268		$	2,358		$	2,115,596		$	(712,148	)	$	1,405,806		$	12,905		$	1,418,711

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine Months Ended September 30,
	2013			2012
Cash flows from operating activities:
Net income (loss)	$	20,622		$	(22,551	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, amortization and other	86,654			85,941
Share-based compensation expense	5,129			12,290
Bad debt expense	107			578
Change in fair value of derivative financial instruments	(8,573		)	7,815
Changes in operating assets and liabilities:
Receivables and other assets	(13,569		)	(4,370		)
Accounts payable and accrued liabilities	21,928			6,560
Security deposits, prepaid rent and other liabilities	6,377			(2,460		)
Net cash provided by operating activities	118,675			83,803
Cash flows from investing activities:
Acquisition of real estate operating properties and other assets	(223,839		)	(230,636		)
Capital expenditures	(16,486		)	(18,341		)
Issuance of real estate notes receivable	(8,520		)	—
Restricted cash, escrow deposits and notes receivable	(2,446		)	(4,840		)
Release of restricted cash	—			580
Real estate deposits paid	—			(3,810		)
Real estate deposits used	—			4,810
Net cash used in investing activities	(251,291		)	(252,237		)
Cash flows from financing activities:
Proceeds from unsecured senior notes	297,558			—
Borrowings on unsecured revolving credit facility	103,000			281,000
Payments on unsecured revolving credit facility	(175,000		)	(268,000		)
Borrowings on unsecured term loans	—			455,000
Payments on secured real estate term loan and mortgage loans	(155,302		)	(106,532		)
Deferred financing costs	(3,471		)	(6,439		)
Derivative financial instrument termination payments	(1,195		)	—
Security deposits	967			551
Proceeds from issuance of common stock, net	229,498			—
Repurchase and cancellation of common stock	(287		)	(182,397		)
Payment of offering costs	—			(2,884		)
Dividends	(95,597		)	(62,457		)
Payment on earnout liability	(92		)	(328		)
Distributions to noncontrolling interest of limited partners	(1,238		)	(231		)
Net cash provided by financing activities	198,841			107,283
Net change in cash and cash equivalents	66,225			(61,151		)
Cash and cash equivalents - beginning of period	15,956			69,491
Cash and cash equivalents - end of period	$	82,181		$	8,340

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

	September 30, 2013			December 31, 2012
ASSETS
Real estate investments:
Land	$	195,115		$	183,651
Building and improvements	2,215,513			2,044,113
Lease intangibles	386,801			352,884
Property held for sale, net	21,138			—
	2,818,567			2,580,648
Accumulated depreciation and amortization	(415,615		)	(349,118		)
Real estate investments, net	2,402,952			2,231,530
Real estate notes receivable	28,520			20,000
Cash and cash equivalents	82,181			15,956
Restricted cash and escrow deposits	20,068			17,623
Receivables and other assets, net	104,996			84,970
Other intangibles, net	41,794			44,011
Non-real estate assets of property held for sale, net	1,009			—
Total assets	$	2,681,520		$	2,414,090
LIABILITIES AND PARTNERS’ CAPITAL
Liabilities:
Debt, net	$	1,125,792		$	1,037,359
Accounts payable and accrued liabilities	86,795			63,443
Derivative financial instruments - interest rate swaps	3,258			9,370
Security deposits, prepaid rent and other liabilities	32,327			24,450
Intangible liabilities, net	11,262			11,309
Total liabilities	1,259,434			1,145,931
Commitments and contingencies
Redeemable noncontrolling interest of limited partners	1,807			1,960
Partners’ Capital:
Limited partners’ capital, 3,053,618 and 3,055,718 units issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	14,203			11,663
General partners’ capital, 235,743,189 and 214,652,641 units issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	1,406,076			1,254,536
Total partners’ capital	1,420,279			1,266,199
Total liabilities and partners’ capital	$	2,681,520		$	2,414,090

The accompanying notes are an integral part of these condensed consolidated financial statements.

8

HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
Revenues:
Rental income	$	81,906		$	76,465		$	234,338		$	220,222
Interest income from real estate notes receivable and other income	635			1,067			1,874			3,683
Total revenues	82,541			77,532			236,212			223,905
Expenses:
Rental	25,774			25,744			72,235			73,038
General and administrative	5,980			5,164			18,645			16,079
Non-traded REIT	—			350			—			4,197
Acquisition-related	1,403			1,341			3,086			6,633
Depreciation and amortization	29,581			29,228			87,554			87,091
Listing	—			4,751			4,405			17,295
Total expenses	62,738			66,578			185,925			204,333
Income (loss) before other income (expense)	19,803			10,954			50,287			19,572
Other income (expense):
Interest expense:
Interest related to debt	(12,146		)	(10,172		)	(35,543		)	(30,648		)
Interest related to derivative financial instruments and net change in fair value of derivative financial instruments	(3,042		)	(3,832		)	5,125			(10,066		)
Debt extinguishment costs	—			—			—			(1,886		)
Other income (expense)	10			(24		)	28			67
Income (loss) from continuing operations	4,625			(3,074		)	19,897			(22,961		)
Income from discontinued operations	380			143			725			410
Net income (loss)	$	5,005		$	(2,931	)	$	20,622		$	(22,551	)
Net income attributable to noncontrolling interests	(9		)	(20		)	(39		)	(28		)
Net income (loss) attributable to controlling interest	$	4,996		$	(2,951	)	$	20,583		$	(22,579	)
Earnings (losses) per unit attributable to controlling interest - basic:
Continuing operations	$	0.02		$	(0.01	)	$	0.09		$	(0.10	)
Discontinued operations	0.00			0.00			0.00			0.00
Net income (loss)	$	0.02		$	(0.01	)	$	0.09		$	(0.10	)
Earnings (losses) per unit attributable to controlling interest - diluted:
Continuing operations	$	0.02		$	(0.01	)	$	0.09		$	(0.10	)
Discontinued operations	0.00			0.00			0.00			0.00
Net income (loss)	$	0.02		$	(0.01	)	$	0.09		$	(0.10	)
Weighted average number of units outstanding:
Basic	235,570			221,413			228,188			227,105
Diluted	235,570			221,413			228,188			227,105
Dividends declared per common unit	$	0.14		$	0.14		$	0.43		$	0.49

The accompanying notes are an integral part of these condensed consolidated financial statements.

9

HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN PARTNERS’ CAPITAL

(In thousands)

(Unaudited)

	General Partners’ Capital					Limited Partners’ Capital					Total Partners’ Capital
	Units		Amount			Units		Amount
Balance as of December 31, 2011	228,491		$	1,567,510		156		$	1,417		$	1,568,927
Issuance of units under the DRIP	3,362		31,915			—		—			31,915
Redemptions of general partner units	(18,150	)	(185,278		)	—		—			(185,278		)
Share-based award transactions, net	679		6,365			2,875		5,925			12,290
Distributions	—		(111,165		)	—		(73		)	(111,238		)
Net income (loss) attributable to controlling interest	—		(22,588		)	—		9			(22,579		)
Balance as of September 30, 2012	214,382		$	1,286,759		3,031		$	7,278		$	1,294,037
Balance as of December 31, 2012	214,652		$	1,254,536		3,056		$	11,663		$	1,266,199
Issuance of general partner units	20,707		228,306			—		—			228,306
Redemptions of general partner units	(28	)	(287		)	—		—			(287		)
Share-based award transactions, net	412		1,952			(2	)	3,177			5,129
Distributions	—		(98,630		)	—		(1,021		)	(99,651		)
Net income (loss) attributable to controlling interest	—		20,199			—		384			20,583
Balance as of September 30, 2013	235,743		$	1,406,076		3,054		$	14,203		$	1,420,279

The accompanying notes are an integral part of these condensed consolidated financial statements.

10

HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine Months Ended September 30,
	2013			2012
Cash flows from operating activities:
Net income (loss)	$	20,622		$	(22,551	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, amortization and other	86,654			85,941
Share-based compensation expense	5,129			12,290
Bad debt expense	107			578
Change in fair value of derivative financial instruments	(8,573		)	7,815
Changes in operating assets and liabilities:
Receivables and other assets	(13,569		)	(4,370		)
Accounts payable and accrued liabilities	21,928			6,560
Security deposits, prepaid rent and other liabilities	6,377			(2,460		)
Net cash provided by operating activities	118,675			83,803
Cash flows from investing activities:
Acquisition of real estate operating properties and other assets	(223,839		)	(230,636		)
Capital expenditures	(16,486		)	(18,341		)
Issuance of real estate notes receivable	(8,520		)	—
Restricted cash, escrow deposits and notes receivable	(2,446		)	(4,840		)
Release of restricted cash	—			580
Real estate deposits paid	—			(3,810		)
Real estate deposits used	—			4,810
Net cash used in investing activities	(251,291		)	(252,237		)
Cash flows from financing activities:
Proceeds from unsecured senior notes	297,558			—
Borrowings on unsecured revolving credit facility	103,000			281,000
Payments on unsecured revolving credit facility	(175,000		)	(268,000		)
Borrowings on unsecured term loans	—			455,000
Payments on secured real estate term loan and mortgage loans	(155,302		)	(106,532		)
Deferred financing costs	(3,471		)	(6,439		)
Derivative financial instrument termination payments	(1,195		)	—
Security deposits	967			551
Proceeds from issuance of general partner units, net	229,498			—
Repurchase and cancellation of general partner units	(287		)	(182,397		)
Payment of offering costs	—			(2,884		)
Distributions to general partner	(95,597		)	(62,457		)
Payment on earnout liability	(92		)	(328		)
Distributions to limited partners and redeemable noncontrolling interests	(1,238		)	(231		)
Net cash provided by financing activities	198,841			107,283
Net change in cash and cash equivalents	66,225			(61,151		)
Cash and cash equivalents - beginning of period	15,956			69,491
Cash and cash equivalents - end of period	$	82,181		$	8,340

The accompanying notes are an integral part of these condensed consolidated financial statements.

11

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Unless otherwise indicated or unless the context requires otherwise the use of the words “we,” “us” or “our” refers to Healthcare Trust of America, Inc. and Healthcare Trust of America Holdings, LP, collectively.

1. Organization and Description of Business

Healthcare Trust of America, Inc., a Maryland corporation, and Healthcare Trust of America Holdings, LP, a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006. Healthcare Trust of America, Inc. (“HTA”) operates as a real estate investment trust, or REIT, and is the general partner of Healthcare Trust of America Holdings, LP (“HTALP”) which is the operating partnership. As of September 30, 2013, HTA owned an approximate 98.94% partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including long term incentive plan units) in HTALP. As the sole general partner of HTALP, HTA has the full, exclusive and complete responsibility for HTALP’s day-to-day management and control. HTA’s only material asset is its ownership of partnership interests of HTALP. As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP, issuing public equity from time to time and guaranteeing certain debt of HTALP. HTALP holds substantially all of the assets of the Company. HTALP conducts the operations of the business of the Company and is structured as a limited partnership with no publicly traded equity.

HTA is a fully integrated, self-administered and internally managed REIT and conducts substantially all of its operations through HTALP. We are primarily focused on acquiring, owning and operating high-quality medical office buildings that are predominantly located on, or aligned with, campuses of nationally or regionally recognized healthcare systems. HTA is one of the largest public REITs focused on medical office buildings in the United States based on gross leasable area, or GLA, and has strong industry relationships, a stable and diversified tenant mix, and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments and to provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we (i) target mid-sized acquisitions of high-quality medical office buildings in markets with dominant healthcare systems, attractive demographics and that complement our existing portfolio, (ii) actively manage our balance sheet to maintain flexibility with conservative leverage, and (iii) seek internal growth through proactive asset management, leasing and property management oversight. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT.

We invest primarily in high-quality medical office buildings in our target markets, and have acquired high-quality medical office buildings and other facilities that serve the healthcare industry with an aggregate purchase price of $2.8 billion through September 30, 2013. As of September 30, 2013, our portfolio consisted of 260 medical office buildings and 19 other facilities that serve the healthcare industry, as well as real estate notes receivable secured by medical office buildings.

On June 6, 2012, HTA listed its Class A common stock on the New York Stock Exchange, or the NYSE, or the Listing. In accordance with an amendment to HTA’s charter approved by stockholders on December 20, 2010, all of the common stock was converted into Class A, Class B-1, Class B-2 and Class B-3 common stock. The Class B common stock is identical to the Class A common stock except that the Class B common stock is not currently listed on a national securities exchange. The shares of the Class B-1 and Class B-2 common stock converted into shares of our Class A common stock on December 6, 2012 and June 6, 2013, respectively, and are now listed on the NYSE. On November 4, 2013, HTA’s Board of Directors announced that the Class B-3 common stock will convert to Class A common stock after the market closes on November 7, 2013 and be eligible for trading on the NYSE.

Our principal executive offices are located at 16435 N. Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.

2. Summary of Significant Accounting Policies

The summary of significant accounting policies presented below is designed to assist in understanding our condensed consolidated financial statements. Such condensed consolidated financial statements and the accompanying notes are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America, or GAAP, in all material respects, and have been consistently applied in preparing our accompanying condensed consolidated financial statements.

12

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Reclassifications

To better present our real estate related balances, we have chosen to break out the details of real estate investments (net) in our balance sheet as opposed to disclosing the details in a footnote. In addition, we have reclassified certain accounts, as further discussed below, in HTA’s previously issued balance sheet to conform to current period presentation. In place leases and tenant relationship intangibles are now included in real estate investments (net) as lease intangibles. In addition, accounts and other receivables (net) have been combined with receivables and other assets (net). None of the revised reclassifications reflect corrections of any amounts. The following table presents the previously reported balances of and the reclassified balances for the impacted line items of the December 31, 2012 balance sheet (in thousands):

	December 31, 2012
	As Previously Reported		As Reclassified
Real estate investments:
Land	$	—	$	183,651
Building and improvements	—		2,044,113
Lease intangibles	—		352,884
	—		2,580,648
Accumulated depreciation and amortization	—		(349,118		)
Real estate investments, net	1,992,607		2,231,530
Accounts and other receivables, net	13,317		—
Receivables and other assets, net	71,653		84,970
Other intangibles, net	282,934		44,011

Real Estate Depreciation

Depreciation expense of buildings and improvements for the three months ended September 30, 2013 and 2012, was $18.9 million and $17.8 million, respectively. Depreciation expense of buildings and improvements for the nine months ended September 30, 2013 and 2012, was $55.5 million and $53.0 million, respectively.

Listing Expenses

Listing expenses primarily include fees associated with the Listing and share-based compensation expense associated with the long term incentive program, or LTIP, awards that we granted in connection with the Listing.

Noncontrolling Interests

HTA’s net income attributable to noncontrolling interests in its accompanying condensed consolidated statements of operations relate to both noncontrolling interest reflected within equity and redeemable noncontrolling interest of limited partners reflected outside of equity in our accompanying condensed consolidated balance sheets. Limited partner units in HTALP are accounted for as partners’ capital in HTALP’s condensed consolidated balance sheets and as noncontrolling interest reflected within equity or redeemable noncontrolling interest of limited partners reflected outside of equity in HTA’s condensed consolidated balance sheets.

Interim Unaudited Financial Data

Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the Securities and Exchange Commission, or the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim period. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in the 2012 Annual Report on Form 10-K for HTA and the Registration Statement on Form S-4 for HTALP, as amended, that was declared effective by the SEC on October 22, 2013 (File No. 333-190916).

13

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Recently Issued or Adopted Accounting Pronouncements

In January 2013, the Financial Accounting Standards Board, or the FASB, issued Accounting Standards Update, or ASU, 2013-01, Balance Sheet (Topic 210) - Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, or ASU 2013-01, which clarifies the scope of ASU 2011-11, Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities. ASU 2013-01 requires entities to disclose both gross and net information about derivatives, including bifurcated embedded derivatives, repurchase agreements and reverse purchase agreements and securities borrowing and securities lending transactions that are subject to an agreement similar to a master netting arrangement. Entities are required to apply these disclosures for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. An entity must provide the disclosures required by those amendments retrospectively for all comparative periods presented. We adopted ASU 2011-11 and ASU 2013-01 in the first quarter of fiscal 2013 and have reflected the adoption in our disclosures to our interim condensed consolidated financial statements.

3. Business Combinations

For the nine months ended September 30, 2013, we have completed seven acquisitions for an aggregate purchase price of $241.9 million, in addition to closing costs attributable to these acquisitions of $1.4 million. Results of operations for these acquisitions are reflected in our condensed consolidated statements of operations for the three and nine months ended September 30, 2013, for the periods subsequent to the acquisition dates.

The aggregate net purchase price of the 2013 acquisitions was allocated in the amounts set forth in the table below. Due to the recent timing of certain acquisitions, we have not yet finalized our purchase price allocation. Since the acquisitions were determined to be individually not significant, but material on a collective basis, the allocations for these acquisitions are set forth below in the aggregate (in thousands):

2013 Acquisitions	Total
Land	$	13,415
Building and improvements	175,039
Below market leasehold interests	1,836
Above market leases	1,987
In place leases	32,205
Tenant relationships	16,541
Below market leases	(1,167		)
Above market debt	(241		)
Net assets acquired	239,615
Other, net	2,299
Aggregate purchase price	$	241,914

The weighted average lives of the above acquired intangible assets and liabilities were 7.4 years and 5.7 years, respectively.

The property acquisitions completed during the nine months ended September 30, 2013, were all cash transactions except for the acquisition on September 20, 2013 and we acquired a 100% ownership interest in each property acquisition. See below for a brief description of each of the acquisitions.

• On March 11, 2013, we completed the acquisition of a medical office building located in Dallas, Texas for $48.7 million.

• On March 22, 2013, we completed the acquisition of a medical office building located in Bryan - College Station, Texas for $39.8 million.

• On June 18, 2013, we completed the acquisition of a medical office building located in Atlanta, Georgia for $5.6 million.

• On July 12, 2013, we completed the acquisition of a medical office property located in Monroeville, Pennsylvania for $15.1 million.

• On July 29, 2013, we completed the acquisition of a medical office building located in Denver, Colorado for $42.0 million.

14

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

• On August 30, 2013, we completed the acquisition of a medical office building located in Dallas, Texas for $27.7 million.

• On September 20, 2013, we completed the acquisition of a portfolio of medical office buildings located in South Florida for $62.9 million. As part of the acquisition, we assumed approximately $18.0 million of mortgage loans.

In addition, we have entered into two definitive purchase agreements for the acquisition of medical office buildings located in Austin, Texas totaling approximately $30.0 million. The closing of these acquisitions are subject to the satisfaction of customary closing conditions.

The aggregate net purchase price of the 2012 acquisitions was allocated in the amounts set forth in the table below. Since the acquisitions were determined to be individually not significant, but material on a collective basis, the allocations for these acquisitions are set forth below in the aggregate (in thousands):

2012 Acquisitions	Total
Land	$	3,809
Building and improvements	214,772
Below market leasehold interests	3,284
Above market leases	4,199
In place leases	23,388
Tenant relationships	19,863
Below market leases	(1,415		)
Net assets acquired	267,900
Other, net	287
Aggregate purchase price	$	268,187

The weighted average lives of the above acquired intangible assets and liabilities were 14.8 years and 7.5 years, respectively.

4. Real Estate Notes Receivable

Real estate notes receivable includes four promissory notes totaling $20.0 million as of September 30, 2013 and December 31, 2012. The promissory notes are secured by medical office buildings, with interest rates ranging from 10.85% to 10.95% per annum. The weighted average effective interest rate based on the purchase price of the notes was 14.57% per annum as of September 30, 2013. The promissory notes matured on November 1, 2013 and we expect to receive payment on the principal balance or extend the maturity date during the quarter ending December 31, 2013. The promissory notes have sufficient collateral coverage based on the value of the medical office buildings. The promissory notes will continue to accrue interest as the same per annum rates and as of September 30, 2013 all interest payments were current.

In addition, we originated two promissory notes in September 2013 totaling $8.5 million. The promissory notes are secured by medical office buildings in South Florida, each with an interest rate of 7.0% per annum. The properties are being actively marketed for sale and the notes will be repaid upon any sale. The promissory notes mature on October 1, 2016.

We monitor the credit quality of our real estate notes receivable on an ongoing basis by tracking possible credit quality indicators. As of September 30, 2013, all of our real estate notes receivable are current and we have not provided for any allowance for losses or recorded any impairments with respect to our notes receivable. We made no purchases or sales of real estate notes receivable during the nine months ended September 30, 2013.

15

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

5. Intangible Assets and Liabilities

Intangible assets and liabilities consisted of the following as of September 30, 2013 and December 31, 2012 (in thousands, except weighted average remaining amortization period):

	September 30, 2013				December 31, 2012
	Balance			Weighted Average Remaining Amortization Period in Years	Balance			Weighted Average Remaining Amortization Period in Years	Balance Sheet Classification
Assets:
In place leases	$	197,185		8.7	$	174,615		9.7	Lease intangibles
Tenant relationships	189,616			10.6	178,269			11.6	Lease intangibles
Above market leases	25,878			6.3	25,387			6.9	Other intangibles, net
Below market leasehold interests	29,128			63.9	30,587			69.4	Other intangibles, net
	441,807				408,858
Accumulated amortization	(143,160		)		(125,924		)
Total	$	298,647			$	282,934
Liabilities:
Below market leases	$	13,548		13.0	$	12,823		13.7	Intangible liabilities, net
Above market leasehold interests	3,827			33.3	3,827			34.0	Intangible liabilities, net
	17,375				16,650
Accumulated amortization	(6,113		)		(5,341		)
Total	$	11,262			$	11,309

The following is a summary of the net intangible amortization for the three and nine months ended September 30, 2013 and 2012 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Amortization recorded against rental income related to above or below market leases	$	417	$	470	$	1,298	$	1,185
Rental expense related to above or below market leasehold interests	89		106		278		413
Amortization expense related to in place leases and tenant relationships	9,955		10,705		29,912		32,151

16

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

6. Receivables and Other Assets

Receivables and other assets consisted of the following as of September 30, 2013 and December 31, 2012 (in thousands):

	September 30, 2013		December 31, 2012
Accounts and other receivables, net	$	19,595	$	13,317
Tenant note receivable	3,202		3,287
Deferred financing costs, net	11,395		11,006
Deferred leasing costs, net	12,223		10,554
Lease inducements, net	762		880
Straight-line rent receivables, net	44,861		39,095
Prepaid expenses, deposits, equipment and other	9,302		6,831
Derivative financial instruments - interest rate swaps	3,656		—
Total	$	104,996	$	84,970

The tenant note receivable is for a loan to a tenant for building improvements. The interest rate thereon is 9.0% per annum and requires monthly principal and interest payments from the tenant through July 2027. As of September 30, 2013, this tenant note receivable is current and we have not provided any allowance for losses, and we have had no impairment with respect to this note receivable.

The following is a summary of amortization of deferred leasing costs, deferred financing costs, and lease inducements for the three and nine months ended September 30, 2013 and 2012 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Amortization expense related to deferred leasing costs	$	686	$	568	$	1,844	$	1,436
Interest expense related to deferred financing costs	805		896		3,030		2,987
Amortization recorded against rental income related to lease inducements	56		54		156		220

7. Assets Held for Sale and Discontinued Operations

During 2013 we classified one of our properties as held for sale as we committed to an approved plan to seek to dispose of the property. The sale of the property is expected to occur within one year. As of December 31, 2012, there were no properties held for sale. The following table represents the major classes of assets and liabilities, and the balance sheet classification as of September 30, 2013 (in thousands):

	September 30, 2013
Land	$	5,109
Building and improvements, net	15,181
Lease intangibles, net	848
Property held for sale, net	$	21,138
Receivables and other assets, net	$	1,009
Non-real estate assets of property held for sale, net	$	1,009
Security deposits, prepaid rent and other liabilities	$	181
Security deposits, prepaid rent and other liabilities	$	181

17

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The table below reflects the results of operations of the property classified as held for sale, which are included in discontinued operations for the three and nine months ended September 30, 2013 and 2012 (in thousands):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2013		2012			2013			2012
Revenues:
Rental income	$	443	$	566		$	1,257		$	1,697
Expenses:
Rental	63		65			200			216
Depreciation and amortization	—		230			171			688
Total expenses	63		295			371			904
Income before other income (expense)	380		271			886			793
Other income (expense):
Interest expense related to debt	—		(128		)	(161		)	(383		)
Income from discontinued operations	$	380	$	143		$	725		$	410

8. Debt

Debt consisted of the following as of September 30, 2013 and December 31, 2012 (in thousands):

	September 30, 2013		December 31, 2012
Unsecured revolving credit facility	$	—	$	72,000
Unsecured term loans	455,000		455,000
Unsecured senior notes	300,000		—
Fixed rate mortgages	370,636		382,456
Secured real estate term loan	—		125,500
	1,125,636		1,034,956
Net premium	156		2,403
Total	$	1,125,792	$	1,037,359

Unsecured Credit Agreement

On March 29, 2012, we entered into an unsecured credit agreement to obtain a $575.0 million unsecured revolving credit facility and a $300.0 million unsecured term loan. On March 7, 2013, we executed an amendment to the unsecured credit agreement pursuant to an existing provision therein to increase the principal amount of the unsecured revolving credit facility. This amendment added an additional lender and increased the unsecured revolving credit facility by $75.0 million to $650.0 million. The other existing terms of the unsecured credit agreement were unchanged. The unsecured credit agreement matures on March 29, 2016 and includes a one-year extension option, subject to certain conditions.

The actual amount of credit available under our unsecured credit agreement is a function of certain loan-to-value and debt service coverage ratios. The maximum principal amount may be increased; subject to such additional financing being provided by our existing lenders or new lenders added to the unsecured revolving credit facility.

Borrowings under the $650.0 million unsecured revolving credit facility accrue interest equal to adjusted LIBOR plus a margin ranging from 1.10% to 1.75% per annum based on our credit rating. We also pay a facility fee ranging from 0.20% to 0.50% per annum on the aggregate commitments under the unsecured revolving credit facility. As of September 30, 2013, the margin associated with borrowings was 1.55% per annum and the facility fee was 0.35% per annum. As of September 30, 2013, no amount was outstanding on our unsecured revolving credit facility.

Borrowings under the $300.0 million unsecured term loan accrue interest equal to adjusted LIBOR plus a margin ranging from 1.30% to 2.25% per annum based on our credit rating. The margin associated with borrowings as of September 30, 2013 was 1.85% per annum. We have interest rate swaps in place that fix the interest rate at 2.95% per annum, based on our current credit rating.

18

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

$155.0 million Unsecured Term Loan

On July 20, 2012, we entered into a $155.0 million unsecured term loan that matures on July 19, 2019. The interest rate thereon is equal to LIBOR plus a margin ranging from 1.55% to 2.40% per annum based on our credit rating. The margin associated with the borrowings as of September 30, 2013 was 2.00% per annum. We have interest rate swaps in place that fix the interest rate at 3.29% per annum, based on our current credit rating. The maximum principal amount may be increased by us, subject to such additional financing being provided by our existing lender.

$300.0 million Unsecured Senior Notes

On March 28, 2013, we issued $300.0 million of unsecured senior notes that mature on April 15, 2023. The unsecured senior notes bear interest at 3.70% per annum payable semi-annually and were offered at 99.186% of the principal amount thereof. The unsecured senior notes include registration rights to the holders, pursuant to which we filed an exchange offer on Form S-4 on October 22, 2013.

Fixed Rate Mortgages

As of September 30, 2013, we had fixed rate mortgages with interest rates ranging from 4.55% to 12.75% per annum and a weighted average interest rate of 5.86% per annum. As part of an acquisition, we assumed two mortgage loans; see Note 3, Business Combinations.

Secured Real Estate Term Loan

On March 28, 2013, we repaid in full the $125.5 million secured real estate term loan. In connection with that repayment, we terminated the secured real estate term loan (and the commitments thereunder) and the related security documents and guarantees. In addition, we terminated the $75.0 million interest rate swap associated with the secured real estate term loan.

Future Debt Maturities

As of September 30, 2013, the principal payments due on our debt for the three months ending December 31, 2013, for each of the next four years ending December 31 and thereafter, is as follows (in thousands):

Year	Amount
2013	$	1,722
2014	6,872
2015	73,128
2016	421,578
2017	99,963
Thereafter	522,373
Total	$	1,125,636

The above scheduled debt maturities do not include the available extension under the unsecured credit agreement as discussed above.

We are required by the terms of our applicable credit agreements to meet various affirmative and negative covenants that we believe are customary for these types of facilities, such as limitations on the incurrence of debt by us, and our subsidiaries that own unencumbered assets, limitations on the nature of HTALP’s business, and limitations on distributions by HTALP and its subsidiaries that own unencumbered assets. Our credit agreements also impose various financial covenants on us, such as a maximum ratio of total indebtedness to total asset value, a minimum ratio of EBITDA to fixed charges, a minimum tangible net worth covenant, a maximum ratio of unsecured indebtedness to unencumbered asset value, rent coverage ratios, and a minimum ratio of unencumbered net operating income to unsecured interest expense. As of September 30, 2013, we believe that we were in compliance with all such financial covenants and reporting requirements. In addition, certain of our credit agreements include events of default provisions that we believe are customary for these types of facilities, including restricting HTA from making dividend distributions to our stockholders in the event we are in default, except to the extent necessary for HTA to maintain its REIT status.

19

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

9. Derivative Financial Instruments

The following table lists the derivative financial instrument assets and (liabilities) held by us as of September 30, 2013 (in thousands):

Notional Amount		Index	Rate		Fair Value			Instrument	Maturity
$	200,000	LIBOR	1.23	%	$	(2,490	)	Swap	3/29/2017
100,000		LIBOR	0.86		(768		)	Swap	6/15/2016
50,000		LIBOR	1.39		882			Swap	7/17/2019
105,000		LIBOR	1.24		2,774			Swap	7/17/2019

The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2012 (in thousands):

Notional Amount			Index	Rate		Fair Value			Instrument	Maturity
$	17,304	(a)	LIBOR	3.79	%	$	(459	)	Swap	9/28/2013
75,000		(a)	LIBOR	1.07		(659		)	Swap	12/31/2013
200,000			LIBOR	1.23		(5,180		)	Swap	3/29/2017
100,000			LIBOR	0.86		(1,310		)	Swap	6/15/2016
50,000			LIBOR	1.39		(909		)	Swap	7/17/2019
105,000			LIBOR	1.24		(853		)	Swap	7/17/2019

(a) We terminated the interest rate swaps in March 2013.

As of September 30, 2013 and December 31, 2012, the gross fair value of our derivative financial instruments was as follows (in thousands):

	Asset Derivatives					Liability Derivatives
	September 30, 2013			December 31, 2012		September 30, 2013			December 31, 2012
Derivatives Not Designated as Hedging Instruments:	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Interest rate swaps	Receivables and other assets	$	3,656	n/a	n/a	Derivative financial instruments	$	3,258	Derivative financial instruments	$	9,370

There were no derivatives offset in our balance sheet as of September 30, 2013 and December 31, 2012. As of September 30, 2013 and December 31, 2012, we had derivatives subject to enforceable master netting arrangements which allow for net cash settlement with the respective counterparties (in thousands):

	September 30, 2013							December 31, 2012
	Gross Amounts		Amounts Subject to Enforceable Master Netting Arrangements			Net Amounts		Gross Amounts		Amounts Subject to Enforceable Master Netting Arrangements		Net Amounts
Asset derivatives	$	3,656	$	(2,490	)	$	1,166	$	—	$	—	$	—
Liability derivatives	3,258		(2,490		)	768		9,370		—		9,370

20

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

For the three and nine months ended September 30, 2013 and 2012, the derivative financial instruments had the following effect on our condensed consolidated statements of operations (in thousands):

Derivatives Not Designated as Hedging Instruments:	Location of Gain (Loss) Recognized	Three Months Ended September 30,						Nine Months Ended September 30,
		2013			2012			2013		2012
Interest rate swaps	Interest related to derivative financial instruments and net change in fair value of derivative financial instruments	$	(1,955	)	$	(2,520	)	$	8,573	$	(7,726	)
Interest rate cap	Interest related to derivative financial instruments and net change in fair value of derivative financial instruments	—			—			—		(89		)

We have agreements with each of our interest rate swap derivative counterparties that contain a provision whereby if we default on certain of our unsecured indebtedness, then our counterparties could declare us in default on our interest rate swap derivative obligations resulting in an acceleration of the indebtedness. In addition, we are exposed to credit risk in the event of non-performance by our derivative counterparties. We believe we mitigate the credit risk by entering into agreements with credit-worthy counterparties. We record counterparty credit risk valuation adjustments on interest rate swap derivative assets in order to properly reflect the credit quality of the counterparty. In addition, our fair value of interest rate swap derivative liabilities is adjusted to reflect the impact of our credit quality. As of September 30, 2013, there have been no termination events or events of default related to our interest rate swaps, except for our voluntary termination as discussed above.

10. Commitments and Contingencies

Litigation

We are not presently subject to any material litigation nor, to our knowledge, is any material litigation threatened against us, which if determined unfavorably to us, would have a material effect on our condensed consolidated financial position, results of operations or cash flows.

Environmental Matters

We follow the policy of monitoring our properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at our properties, we are not currently aware of any environmental liability with respect to our properties that would have a material effect on our condensed consolidated financial position, results of operations or cash flows. Further, we are not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability at our properties that we believe would require additional disclosure or the recording of a loss contingency.

Other

Our other commitments and contingencies include the usual obligations of real estate owners and operators in the normal course of business. In our opinion, these matters are not expected to have a material effect on our condensed consolidated financial position, results of operations or cash flows.

11. Stockholders’ Equity and Partners’ Capital

HTALP’s partnership agreement provides that it will distribute cash flows from operations and net sale proceeds to its partners in accordance with their overall ownership interests at such times and in such amounts as the general partner determines. Except for certain LTIP units that have not vested, dividend distributions are made such that a holder of one unit will receive annual dividend distributions from HTALP in an amount equal to the annual dividends paid to the holder of one of HTA’s shares. In addition, for each share of common stock issued or redeemed by HTA, HTALP issues or redeems a corresponding number of units.

Common Stock Offerings

On January 7, 2013, HTA commenced an equity at-the-market, or ATM, offering of its Class A common stock with an aggregate sales price of up to $250.0 million. During the nine months ended September 30, 2013, HTA issued and sold 20,707,113 shares, at an average price of $11.24 per share. On November 1, 2013, HTA terminated this ATM offering and commenced a new ATM offering of its Class A common stock with an aggregate sales price of up to $300.0 million.

21

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Common Stock Dividends

The following are the cash dividends declared by HTA on all Class A and B common stock during 2013:

Declaration Date	Record Date	Amount Per Share		Payment Date
January 18, 2013	March 29, 2013	$	0.14375	April 4, 2013
April 26, 2013	June 27, 2013	0.14375		July 3, 2013
August 1, 2013	September 27, 2013	0.14375		October 4, 2013
November 4, 2013	December 27, 2013	0.14375		January 3, 2014

Incentive Plan

Our Amended and Restated 2006 Plan, or the Plan, permits the grant of incentive awards to our employees, officers, non-employee directors, and consultants as selected by our Board of Directors or the Compensation Committee. The Plan authorizes the granting of awards in any of the following forms: options; stock appreciation rights; restricted stock; restricted or deferred stock units; performance awards; dividend equivalents; other stock-based awards, including units in HTALP; and cash-based awards. The service period is generally three or four years. Subject to adjustment as provided in the Plan, the aggregate number of awards reserved and available for issuance under the Plan is 10,000,000. As of September 30, 2013, there were 5,096,100 awards available for grant under the Plan.

Long Term Incentive Program of OP Units

Awards under the LTIP consist of Series C units in HTALP, and are subject to the achievement of certain performance and market conditions in order to vest. Once vested, the Series C units are converted into common units of HTALP, which may be converted into shares ofHTA’scommon stock.

For thethree and nine months ended September 30, 2013, we recognized compensation expense related to LTIP awards of$0.0 million and $3.1 million, respectively, which was recorded in listing expenses. For thethree and nine months ended September 30, 2012, we recognized compensation expense related to LTIP awards of$4.5 millionand$5.9 million, respectively, which was recorded in listing expenses. As ofSeptember 30, 2013, there was approximately$4.5 millionof unrecognized expense associated with450,000units that will only vest as a result of a change in control. We will not recognize any expense associated with these units until such event occurs or is probable.

The following is a summary of the activity in our LTIP units during 2013:

	LTIP Units		Weighted Average Grant Date Fair Value
Balance as of December 31, 2012	2,900,000		$	6.25
Granted	—		—
Vested	(2,380,700	)	5.56
Forfeited	(2,100	)	5.62
Balance as of September 30, 2013	517,200		$	9.42

Restricted Common Stock

For the three months ended September 30, 2013, we recognized compensation expense of $0.5 million, which was recorded in general and administrative expenses. For the nine months ended September 30, 2013, we recognized compensation expense of $2.0 million, of which $1.4 million was recorded in general and administrative expenses and $0.6 million was recorded in listing expenses. For the three months ended September 30, 2012, we recognized compensation expense of $0.2 million, which was recorded in general and administrative expenses. For the nine months ended September 30, 2012, we recognized compensation expense of $6.4 million, of which $0.2 million was recorded in general and administrative expenses, $4.7 million was recorded in listing expenses, and $1.5 million was recorded in non-traded REIT expenses.

As of September 30, 2013, there was approximately $4.2 million of unrecognized compensation expense net of estimated forfeitures, related to nonvested shares of restricted common stock which will be recognized over a remaining weighted average period of 2.3 years.

22

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The following is a summary of the activity in our restricted common stock during 2013:

	Restricted Common Stock		Weighted Average Grant Date Fair Value
Balance as of December 31, 2012	376,500		$	9.98
Granted	475,500		10.56
Vested	(92,500	)	10.10
Forfeited	(63,500	)	10.00
Balance as of September 30, 2013	696,000		$	10.35

12. Fair Value of Financial Instruments

Financial Instruments Reported at Fair Value

Derivative Financial Instruments

Currently, we use interest rate swaps to manage interest rate risk associated with variable rate debt. The valuation of these instruments is determined with the assistance of an independent valuation specialist using a proprietary model that utilizes widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative, and observable inputs. As such, we classify these inputs as Level 2. The proprietary model reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates, and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves.

We incorporate credit valuation adjustments to appropriately reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees.

Although we have determined that the majority of the inputs used to value our interest rate swap derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. However, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our interest rate swap derivative positions and have determined that the credit valuation adjustments are not significant to their overall valuation. As a result, we have determined that our interest rate swap derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.

Assets and Liabilities at Fair Value

The table below presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2013, aggregated by the level in the fair value hierarchy (in thousands):

	Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1 )		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets:
Derivative financial instruments	$	—	$	3,656	$	—	$	3,656
Total assets at fair value	$	—	$	3,656	$	—	$	3,656
Liabilities:
Derivative financial instruments	$	—	$	3,258	$	—	$	3,258
Total liabilities at fair value	$	—	$	3,258	$	—	$	3,258

23

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2012, aggregated by the level in the fair value hierarchy (in thousands):

	Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1 )		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets:
Derivative financial instruments	$	—	$	—	$	—	$	—
Total assets at fair value	$	—	$	—	$	—	$	—
Liabilities:
Derivative financial instruments	$	—	$	9,370	$	—	$	9,370
Total liabilities at fair value	$	—	$	9,370	$	—	$	9,370

There have been no transfers of assets or liabilities between levels. We will record any such transfers at the end of the reporting period in which a change of event occurs that results in a transfer.

Financial Instruments Disclosed at Fair Value

We consider the carrying values of cash and cash equivalents, accounts and other receivables (net), restricted cash and escrow deposits, and accounts payable and accrued liabilities to approximate fair value for these financial instruments because of the short period of time between origination of the instruments and their expected realization. All of these financial instruments are considered Level 2. The following table sets forth the carrying value and fair value of our real estate notes receivable, tenant note receivable and debt (net) (in thousands):

		September 30, 2013				December 31, 2012
	Fair Value Level	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Real estate notes receivable	2	$	28,520	$	28,520	$	20,000	$	20,000
Tenant note receivable	2	3,202		3,098		3,287		3,337
Debt, net	2	1,125,792		1,149,460		1,037,359		1,087,168

24

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

13. Per Share Data

We include unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents as “participating securities” pursuant to the two-class method. The resulting classes are our common stock and restricted stock. For the three and nine months ended September 30, 2013 and 2012, all of our earnings were distributed and the calculated earnings (losses) per share amount would be the same for all classes.

For the three and nine months ended September 30, 2012, approximately 156,000 shares of HTA were excluded from the computation of diluted shares as their impact would have been anti-dilutive. The following is the reconciliation of the numerator and denominator used in basic and diluted earnings (losses) per share of HTA (in thousands, except per share data):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2013		2012			2013		2012
Numerator:
Income (loss) from continuing operations attributable to controlling interest	$	4,443	$	(3,095	)	$	19,474	$	(22,998	)
Discontinued operations	380		143			725		410
Net income (loss) attributable to controlling interest	$	4,823	$	(2,952	)	$	20,199	$	(22,588	)
Denominator:
Weighted average number of shares outstanding - basic	232,514		218,264			225,132		225,501
Dilutive shares	2,509		—			1,639		—
Weighted average number of shares outstanding - diluted	235,023		218,264			226,771		225,501
Earnings (losses) per share attributable to controlling interest - basic:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Earnings (losses) per share attributable to controlling interest - diluted:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)

25

HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

14. Per Unit Data

The following is the reconciliation of the numerator and denominator used in basic and diluted earnings (losses) per unit of HTALP (in thousands, except per unit data):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2013		2012			2013		2012
Numerator:
Income (loss) from continuing operations attributable to controlling interest	$	4,616	$	(3,094	)	$	19,858	$	(22,989	)
Discontinued operations	380		143			725		410
Net income (loss) attributable to controlling interest	$	4,996	$	(2,951	)	$	20,583	$	(22,579	)
Denominator:
Weighted average number of units outstanding - basic	235,570		221,413			228,188		227,105
Dilutive units	—		—			—		—
Weighted average number of units outstanding - diluted	235,570		221,413			228,188		227,105
Earnings (losses) per unit attributable to controlling interest - basic:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Earnings (losses) per unit attributable to controlling interest - diluted:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)

15. Supplemental Cash Flow Information

The following is the supplemental cash flow information for the nine months ended September 30, 2013 and 2012 (in thousands):

	Nine Months Ended September 30,
	2013		2012
Interest paid	$	27,743	$	30,681
Income taxes paid	904		840
Supplemental Disclosure of Noncash Activities:
Investing Activities:
Accrued capital expenditures	$	2,227	$	1,508
Note receivable included in the consideration for the acquisition of a building	—		37,264
The following represents the significant increase (decrease) in certain assets and liabilities in connection with our acquisition of operating properties:
Debt	$	17,982	$	—
Financing Activities:
Issuances under the DRIP	$	—	$	31,915
Dividend distributions declared, but not paid, including under the DRIP	34,238		30,959
Offering costs transferred to equity/partners’ capital	1,192		—

26

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The use of the words “we,” “us” or “our” refers to Healthcare Trust of America, Inc. (“HTA”) and Healthcare Trust of America Holdings, LP (“HTALP”) collectively.

The following discussion should be read in conjunction with our condensed consolidated financial statements and notes appearing elsewhere in this Quarterly Report on Form 10-Q, as well as with the audited consolidated financial statements, accompanying notes, and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the 2012 Annual Report on Form 10-K for HTA and the Registration Statement on Form S-4 for HTALP, as amended, that was declared effective by the SEC on October 22, 2013 (File No. 333-190916). Such condensed consolidated financial statements and information have been prepared to reflect HTA’s and HTALP’s financial position as of September 30, 2013 and December 31, 2012, together with results of operations for the three and nine months ended September 30, 2013 and 2012, and cash flows for the nine months ended September 30, 2013 and 2012.

Forward-Looking Statements

Certain statements contained in this Quarterly Report on Form 10-Q constitute forward-looking statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act). Such statements include, in particular, statements about our plans, strategies and prospects and estimates regarding future medical office building market performance. Additionally, such statements are subject to certain risks and uncertainties, as well as known and unknown risks, which could cause actual results to differ materially and in adverse ways from those projected or anticipated. Therefore, such statements are not intended to be a guarantee of our performance in future periods. Forward-looking statements are generally identifiable by the use of such terms such as “expect,” “project,” “may,” “should,” “could,” “would,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “opinion,” “predict,” “potential,” “pro forma” or the negative of such terms and other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this Quarterly Report on Form 10-Q is filed with the SEC. We cannot guarantee the accuracy of any such forward-looking statements contained in this Quarterly Report on Form 10-Q, and we do not intend to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Any such forward-looking statements reflect our current views about future events, are subject to unknown risks, uncertainties, and other factors, and are based on a number of assumptions involving judgments with respect to, among other things, future economic, competitive and market conditions, all of which are difficult or impossible to predict accurately. To the extent that our assumptions differ from actual results, our ability to meet such forward-looking statements, including our ability to generate positive cash flow from operations, provide dividends to stockholders, and maintain the value of our real estate properties, may be significantly hindered. Factors that might impair our ability to meet such forward-looking statements include, without limitation, those discussed in Part I, Item 1A “Risk Factors” in the 2012 Annual Report on Form 10-K for HTA and “Risk Factors” in the Registration Statement on Form S-4 for HTALP, as amended, that was declared effective by the SEC on October 22, 2013 (File No. 333-190916), which are incorporated herein by reference.

Forward-looking statements express expectations of future events. All forward-looking statements are inherently uncertain as they are based on various expectations and assumptions concerning future events and they are subject to numerous known and unknown risks and uncertainties that could cause actual events or results to differ materially from those projected. Due to these inherent uncertainties, our stockholders are urged not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date made. In addition, we undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to projections over time, except as required by law.

These risks and uncertainties should be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. Additional information concerning us and our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the SEC.

27

Overview and Background

HTA is a fully integrated, self-administered and internally managed REIT and conducts substantially all of its operations through HTALP. We are primarily focused on acquiring, owning and operating high-quality medical office buildings that are predominantly located on, or aligned with, campuses of nationally or regionally recognized healthcare systems. HTA is one of the largest public REITs focused on medical office buildings in the United States based on GLA, and has strong industry relationships, a stable and diversified tenant mix, and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments and to provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we (i) target mid-sized acquisitions of high-quality on-campus medical office buildings in markets with dominant healthcare systems, attractive demographics and that complement our existing portfolio, (ii) actively manage our balance sheet to maintain flexibility with low leverage, and (iii) seek internal growth through proactive asset management, leasing and property management. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT.

We invest primarily in high-quality medical office buildings in our target markets, and have acquired high-quality medical office buildings and other facilities that serve the healthcare industry with an aggregate purchase price of $2.8 billion through September 30, 2013. As of September 30, 2013, our portfolio consisted of 260 medical office buildings and 19 other facilities that serve the healthcare industry, as well as real estate notes receivable secured by medical office buildings. Our portfolio is comprised of approximately 13.6 million square feet of GLA, with an occupancy rate of approximately 91.4%, including month-to-month leases and leases we have executed, but which have not yet commenced. Approximately 96% of our portfolio, based on GLA, is located on, or aligned with, campuses of nationally or regionally recognized healthcare systems. Our portfolio is diversified geographically across 27 states, with no state having more than 13% of the total GLA as of September 30, 2013. We are concentrated in locations that we have determined to be strategic based on demographic trends and projected demand for medical office buildings, and we expect to continue to invest in these markets. We have concentrations in the following key markets: Phoenix, Arizona; Pittsburgh, Pennsylvania; Greenville, South Carolina; Indianapolis, Indiana; Albany, New York; Houston, Texas; Atlanta, Georgia; Dallas, Texas; Boston, Massachusetts; Miami, Florida; and Denver, Colorado.

Company Highlights

Portfolio Operating Performance

• For the three months ended September 30, 2013, we had net income of $5.0 million, compared to a net loss of $2.9 million for the three months ended September 30, 2012. For the nine months ended September 30, 2013, we had net income of $20.6 million, compared to a net loss of $22.6 million for the nine months ended September 30, 2012.

• HTA’s normalized funds from operations, or Normalized FFO, was $0.16 per diluted share or $37.9 million, and $0.16 per diluted share or $35.4 million, for the three months ended September 30, 2013 and 2012, respectively. HTALP’s Normalized FFO was $0.16 per diluted unit or $37.9 million, and $0.16 per diluted unit or $35.4 million, for the three months ended September 30, 2013 and 2012, respectively.

For a reconciliation of Normalized FFO to net income or loss attributable to controlling interest and an explanation why we present this non-GAAP financial measure, see “Funds from Operations and Normalized Funds from Operations” below.

• For the three months ended September 30, 2013, our total revenue increased 6.5%, or $5.0 million, to $82.5 million, as compared to the three months ended September 30, 2012. For the nine months ended September 30, 2013, our total revenue increased 5.5%, or $12.3 million, to $236.2 million, as compared to the nine months ended September 30, 2012.

• For the three months ended September 30, 2013, our net operating income, or NOI, increased9.3%, or $4.9 million, to $57.1 million, as compared to the three months ended September 30, 2012. For the nine months ended September 30, 2013, NOI increased8.3%, or $12.7 million, to $165.0 million, as compared to the nine months ended September 30, 2012.

For a reconciliation of NOI to net income or loss and an explanation why we present this non-GAAP financial measure, see “NOI, Cash NOI and Same-Property Cash NOI” below.

• For the three months ended September 30, 2013, our Same-Property Cash NOI increased 3.2%, or $1.6 million, to $50.3 million, as compared to the three months ended September 30, 2012. For the nine months ended September 30, 2013, our Same-Property Cash NOI increased 3.0%, or $3.9 million, to $134.8 million, as compared to the nine months ended September 30, 2012.

For a reconciliation of Same-Property Cash NOI to net income or loss and an explanation why we present this non-GAAP financial measure, see “NOI, Cash NOI and Same-Property Cash NOI” below.

28

Internal Growth through Proactive Asset Management, Leasing and Property Management

• Our portfolio of 13.6 million square feet of GLA is focused on strategically located, on-campus or aligned medical office buildings in locations with high barriers to entry. As of September 30, 2013, approximately 96% of our portfolio, based on GLA, is located on, or aligned with, campuses of nationally and regionally recognized healthcare systems.

• Investment grade rated tenants as a percent of annualized base rent was approximately 40% at September 30, 2013. We continue to focus on building relationships with strong tenants and health systems that are leaders in their markets. As of September 30, 2013, approximately 56% of our annualized base rent was derived from tenants that have (or whose parent companies have) a credit rating from a nationally recognized rating agency.

• As of September 30, 2013, our in-house property management and leasing platform operated 11.8 million square feet, or 86% of our current GLA.

• The occupancy rate on our portfolio of properties, including month-to-month leases and leases that have been executed, but which have not yet commenced, was approximately 91.4% as of September 30, 2013. Tenant retention for the portfolio was approximately 82% for the quarter and 84% for the year-to-date, which we believe is indicative of our commitment to maintaining high-quality buildings in desirable locations and fostering strong tenant relationships. Tenant retention is calculated by taking the sum of the total GLA of tenants that renew an expiring lease divided by the total GLA of expiring leases.

Relationship-Focused Growth Strategy

We have been one of the most active investors in the medical office sector over the last 6 years and have developed significant industry relationships with health systems, physician practices, and regional medical office developers and management firms. These relationships are the source of the majority of our opportunities, including more than 80% of our 2013 acquisitions.

• On March 11, 2013, we completed the acquisition of a medical office building located in Dallas, Texas for $48.7 million. This building is approximately 130,000 square feet and was 100% leased at acquisition.

• On March 22, 2013, we completed the acquisition of a medical office building located in Bryan - College Station, Texas for $39.8 million. This building is approximately 124,000 square feet and was 100% leased at acquisition.

• On June 18, 2013, we completed the acquisition of a medical office building located in Atlanta, Georgia for $5.6 million. This building is approximately 23,000 square feet and was 100% leased at acquisition.

• On July 12, 2013, we completed the acquisition of a medical office property located in Monroeville, Pennsylvania for $15.1 million. This building is approximately 116,000 square feet and was 98% leased at acquisition.

• On July 29, 2013, we completed the acquisition of a medical office building located in Denver, Colorado for $42.0 million. This building is approximately 115,000 square feet and was 95% leased at acquisition.

• On August 30, 2013, we completed the acquisition of a medical office building located in Dallas, Texas for $27.7 million. This building is approximately 91,000 square feet and was 100% leased at acquisition.

• On September 20, 2013, we completed the acquisition of a portfolio of medical office buildings located in South Florida for $62.9 million. This portfolio is approximately 428,000 square feet and was 88% leased at acquisition.

Financial Strategy and Balance Sheet Flexibility

• In January 2013, HTA launched a $250.0 million equity ATM offering of its Class A common stock. During the nine months ended September 30, 2013, HTA issued and sold approximately 20.7 million shares, at an average price of $11.24 per share. On November 1, 2013, HTA terminated this ATM offering program and commenced a new ATM offering of its Class A common stock with an aggregate sales price of up to $300.0 million.

• As of September 30, 2013, we had total liquidity of $732.2 million, including cash and cash equivalents of $82.2 million and $650.0 million available on our unsecured revolving credit facility. Our leverage ratio of total debt to total capitalization was 31.0%.

Corporate Strategies

Maximize Internal Growth through Proactive Asset Management, Leasing and Property Management Oversight

Our asset management strategy focuses on achieving internal growth through initiatives to lease vacant space and increase rental rates while maximizing operating efficiencies at our properties. Specific components of our overall strategy include:

29

• migrating our properties toward our in-house property management and leasing platform in geographic areas where we have significant portfolio concentrations and can achieve the necessary scale (approximately 86% of our total GLA was managed internally at September 30, 2013);

• leveraging and proactively partnering with property management and leasing companies with local market expertise in certain circumstances where our in-house property management platform is not currently active;

• increasing our average rental rates, maintaining or increasing renewal rates and actively leasing our vacant space;

• improving the quality of service provided to our tenants by being attentive to their needs, managing expenses, and strategically investing capital;

• maintaining the high quality of our properties and building our reputation as a desirable and recognized landlord;

• maintaining regional offices in markets where we have a significant presence, which enables us to (i) create closer relationships with national and regional healthcare systems and other tenants, and (ii) better respond to their needs; and

• using market knowledge and economies of scale to continually reduce our operating costs.

We believe that we are well-positioned for future rental growth in our medical office buildings. We believe that we will be able to generate cash flow growth through the leasing of vacant space in our medical office buildings as well as rent increases, particularly due to the limited supply of medical office space, the recovering economy and the general reluctance of medical office building tenants to move or relocate because of the desire to remain close to nationally or regionally affiliated healthcare systems. As of September 30, 2013, our occupancy rate was approximately 91.4%, including month-to-month leases and leases that we have executed, but which have not yet commenced.

Achieve Growth through Targeted Acquisitions

We plan to continue to focus primarily on mid-sized acquisitions, in the $25 million to $75 million range, of high-quality medical office buildings in our target markets as discussed above. We also have completed larger acquisitions from time to time and expect to continue to do so in the future when attractive opportunities emerge. In particular, we seek to acquire properties that have the following attributes:

▪ that have stabilized occupancy and are located on-campus or aligned with nationally or regionally recognized healthcare systems in major U.S. metropolitan areas. We believe on-campus or aligned locations tend to provide for better tenant retention rates and rental rate growth as compared to unaffiliated facilities;

• that are affiliated with the country’s top healthcare systems, which typically attract high quality physicians. We will seek healthcare systems with dominant market share, high credit quality and those investing capital into their campuses;

• that are located in high-growth primary and secondary markets with attractive demographics and favorable regulatory environments in business-friendly states or those with high barriers to entry, especially those in which we can achieve operational and leasing efficiency; and

• that create a mix of multi-tenant buildings with greater market-driven growth opportunities and long-term leases with leading credit rated health systems.

Leverage and Expand Our Strategic Relationships to Generate New Opportunities

In order to access acquisition opportunities for our future growth, we plan to continue to emphasize building long-term relationships, cultivated by our senior management team, with key industry participants, which have traditionally provided us with valuable sources of potential investment opportunities. We have significant relationships with large and nationally recognized healthcare systems such as Ascension Health, Banner Health, Deaconess Health System, Forest Park Medical Center, Greenville Hospital System, Highmark, Hospital Corporation of America, Indiana University Health, Piedmont Healthcare, Steward Health Care System, Tenet Healthcare and Wellmont Health System. We also have significant relationships with local and regional developers which we believe stems from the fact that we are not in the development business and, thus, the developers consider us safe and non-conflicted partners with whom they can do business.Through these relationships, we believe that we have developed a reputation of reliability and trustworthiness that produces high tenant satisfaction. In this regard, approximately 73% of our acquisitions since January 2009, based on purchase price, were sourced directly from hospitals and developers. We intend to continue building upon our existing relationships with healthcare systems to establish long-term lease arrangements, and to develop other strategic alignments with new healthcare systems with whom we have not done business.

30

Actively Maintain Strong, Flexible Capital Structure and Balance Sheet

We seek to actively manage our balance sheet to maintain conservative leverage and financing flexibility with carefully staged debt maturities, thereby positioning ourselves to take advantage of strategic investment opportunities. We believe our borrowing capacity under our unsecured revolving credit facility, as well as our access to other sources of debt and equity capital, while remaining within our targeted leverage range, should allow us to capitalize on favorable acquisition opportunities that arise. While we believe our unsecured revolving credit facility will enable us to take advantage of acquisition opportunities on a short-term basis, we intend to take advantage of multiple sources of capital that we can use to effectively manage our long-term leverage strategy, repay our debt maturities, or finance future acquisition opportunities. These other sources of capital include public debt and equity, unsecured bank loans and secured property-level debt. Over the long-term, we intend to continue migrating to a predominately unsecured capital structure. We also will seek to maintain our investment grade credit ratings, which we first received in July 2011 and was most recently re-affirmed in March 2013 with a positive outlook. We believe this is important to preserving our access to these capital sources on favorable terms. In addition, we may also pursue dispositions of properties that we believe no longer align with our strategic objectives in order to redeploy capital.

Factors Which May Influence Results of Operations

We are not aware of any material trends or uncertainties, other than national economic conditions affecting real estate generally and those risks listed in Part II, Item 1A of this report and the risk factors previously disclosed in Part I, Item 1A in our 2012 Annual Report on Form 10-K for HTA and in the Registration Statement for Form S-4 for HTALP, as amended, that was declared effective by the SEC on October 22, 2013 (File No. 333-190916), that may reasonably be expected to have a material impact, favorable or unfavorable, on revenues or income from the acquisition, management and operation of our properties.

Rental Income

The amount of rental income generated by our properties depends principally on our ability to maintain the occupancy rates of currently leased space and to lease currently available space and space that will become available from unscheduled lease terminations at the existing rental rates. Negative trends in one or more of these factors could adversely affect our rental income in future periods.

Acquisitions

During the nine months ended September 30, 2013, we completed seven acquisitions for an aggregate purchase price of $241.9 million. The amount of additional acquisitions could have a significant impact on our results of operations in future periods.

Results of Operations

Comparison of the Three and Nine Months Ended September 30, 2013 and 2012

Except where otherwise noted, the change in our results of operations is primarily due to the increase in the number of geographically diverse properties that we owned and operated. As of September 30, 2013, we owned and operated 260 medical office buildings and 19 other facilities that serve the healthcare industry, comprised of approximately 13.6 million square feet of GLA. As of September 30, 2012, we owned and operated 246 medical office buildings and 19 other facilities that serve the healthcare industry, comprised of approximately 12.5 million square feet of GLA. All explanations are applicable to both HTA and HTALP unless otherwise noted.

Rental Income

For the three months ended September 30, 2013 and 2012, rental income attributable to our properties was $81.9 million and $76.5 million, respectively. For the three months ended September 30, 2013, rental income was comprised of contractual rental income of $79.5 million, straight-line rent of $2.1 million and other operating revenue of $0.3 million. For the three months ended September 30, 2012, rental income was comprised of contractual rental income of $73.9 million, straight-line rent of $2.4 million and other operating revenue of $0.2 million. This increase in rental income is primarily due to the increase in the number of properties in our portfolio and leasing activity.

For the nine months ended September 30, 2013 and 2012, rental income attributable to our properties was $234.3 million and $220.2 million, respectively. For the nine months ended September 30, 2013, rental income was comprised of contractual rental income of $227.4 million, straight-line rent of $6.1 million and other operating revenue of $0.8 million. For the nine months ended September 30, 2012, rental income was comprised of contractual rental income of $211.5 million, straight-line rent of $7.8 million and other operating revenue of $0.9 million. This increase in rental income is primarily due to the increase in the number of properties in our portfolio and leasing activity.

31

Rental Expenses

For the three months ended September 30, 2013 and 2012, rental expenses attributable to our properties were $25.8 million and $25.7 million, respectively. For the nine months ended September 30, 2013 and 2012, rental expenses attributable to our properties were $72.2 million and $73.0 million, respectively. This decrease in rental expenses for the nine months ended September 30, 2013, as compared to the same period in 2012, is primarily due to decreased operating expenses as the result of transitioning additional properties to our in-house asset management platform and the movement of certain operating expenses to direct tenant obligations, partially offset by the increase in the number of properties in our portfolio.

General and Administrative Expenses

For the three months ended September 30, 2013 and 2012, general and administrative expenses were $6.0 million and $5.2 million, respectively. For the nine months ended September 30, 2013 and 2012, general and administrative expenses were $18.6 million and $16.1 million, respectively. General and administrative expenses include such costs as salaries, corporate office overhead, professional and legal fees, among others.  The increase in general and administrative expenses for both the three and nine months ended September 30, 2013, as compared to the same periods in 2012, is primarily related to certain expenses associated with our transition to a publicly traded company and some additional expense associated with our leasing teams.

Non-Traded REIT Expenses

We had no non-traded REIT expenses during the three and nine months ended September 30, 2013. For the three and nine months ended September 30, 2012, non-traded REIT expenses were $0.4 million and $4.2 million, respectively. Non-traded REIT expenses included stockholder services costs and share-based compensation expense attributable to our executives and Board of Directors, as these awards were applicable to past services relative to our non-traded REIT status.

Acquisition-Related Expenses

For the three months ended September 30, 2013 and 2012, acquisition-related expenses were $1.4 million and $1.3 million, respectively. For the nine months ended September 30, 2013 and 2012, acquisition-related expenses were $3.1 million and $6.6 million, respectively. The decrease in acquisition-related expenses for the nine months ended September 30, 2013, as compared to the same period in 2012, is primarily due to certain acquisition related payments in 2012.

Depreciation and Amortization Expense

For the three months ended September 30, 2013 and 2012, depreciation and amortization expense was $29.6 million and $29.2 million, respectively. For the nine months ended September 30, 2013 and 2012, depreciation and amortization expense was $87.6 million and $87.1 million, respectively. This increase in depreciation and amortization expense for the three and nine months ended September 30, 2013, as compared to the same periods in 2012, is primarily due to the increase in our portfolio. The increase during the nine months ended September 30, 2013 is partially offset by the acceleration of certain lease intangibles during 2012.

Listing Expenses

For the three months ended September 30, 2012, listing expenses were $4.8 million. We had no listing expenses for the three months ended September 30, 2013. For the nine months ended September 30, 2013 and 2012, listing expenses were $4.4 million and $17.3 million, respectively. Listing expenses primarily included professional fees and share-based compensation expense associated with the LTIP awards that were granted in connection with the Listing. Listing expenses were higher during the three and nine months ended September 30, 2012, as compared to the same periods in 2013, as result of the Listing in June 2012.

32

Interest Expense and Net Change in Fair Value of Derivative Financial Instruments

Interest expense and net change in the fair value of derivative financial instruments for the three and nine months ended September 30, 2013 and 2012, consisted of the following (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013			2012
Interest expense related to our debt	$	10,736	$	8,845	$	30,758		$	26,131
Amortization of deferred financing costs and debt discount/premium	809		813		2,992			2,848
Unused credit facility fees	601		514		1,793			1,669
Total	12,146		10,172		35,543			30,648
Interest expense related to our derivative financial instruments	1,087		1,312		3,448			2,251
Net (gain) loss on change in fair value of derivative financial instruments	1,955		2,520		(8,573		)	7,815
Total	3,042		3,832		(5,125		)	10,066
Total interest expense and net change in fair value of derivative financial instruments	$	15,188	$	14,004	$	30,418		$	40,714

Total interest expense and net change in the fair value of derivative financial instruments increased during the three months ended September 30, 2013, as compared to the same period 2012, primarily due to the increase in net debt. Total interest expense and net change in the fair value of derivative financial instruments decreased during the nine months ended September 30, 2013, as compared to the same period in 2012, primarily due to the net change in the fair value of derivative financial instruments, partially offset due to the increase in net debt. During the nine months ended September 30, 2013, the fair market value of our derivatives increased $8.6 million, as compared to net decreases of $7.8 million during 2012. This was primarily the result of a higher LIBOR yield curve during 2013, which favorably impacted the fair market value. Net debt increased by $125.3 million from September 2012 to September 2013.

We use interest rate swaps in order to minimize the impact of fluctuations in interest rates. To achieve our objectives, we borrow at fixed rates and variable rates. We also enter into derivative financial instruments, such as interest rate swaps, in order to mitigate our interest rate risk on a related financial instrument. We do not enter into derivative or interest rate transactions for speculative purposes. Derivatives not designated as hedges are not speculative and are used to manage our exposure to interest rate movements.

Debt Extinguishment Costs

For the nine months ended September 30, 2012, debt extinguishment costs were $1.9 million as a result of the early retirement of certain mortgage loans in the second quarter of 2012. There were no debt extinguishment costs during 2013.

Funds from Operations and Normalized Funds from Operations

We compute funds from operations, or FFO, in accordance with the current standards established by the National Association of Real Estate Investment Trusts, or NAREIT. NAREIT defines FFO, as net income or loss attributable to controlling interests (computed in accordance with GAAP), excluding gains or losses from sales of property and impairment write-downs of depreciable assets, plus depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. We present this non-GAAP financial measure because we consider it an important supplemental measure of our operating performance and believe it is frequently used by securities analysts, investors and other interested parties in the evaluation of REITs. Historical cost accounting assumes that the value of real estate assets diminishes ratably over time. Since real asset values have historically risen or fallen based on market conditions, many industry investors have considered presentation of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. Because FFO excludes depreciation and amortization unique to real estate, among other items, it provides a perspective not immediately apparent from net income or loss attributable to controlling interest.

Our methodology for calculating FFO may be different from methods utilized by other REITs and, accordingly, may not be comparable to such other REITs. FFO should not be considered as an alternative to net income or loss attributable to controlling interest (computed in accordance with GAAP) as an indicator of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity, nor is it indicative of sufficient cash flow to fund all of our needs. FFO should be reviewed in connection with other GAAP measurements.

33

We also compute Normalized FFO, which excludes from FFO acquisition-related expenses, listing expenses, net change in fair value of derivative financial instruments, noncontrolling income from partnership units included in diluted shares (only applicable to HTA), transitional expenses, acceleration of deferred financing costs, escrow settlement revenue, debt extinguishment costs and other normalizing items. We present this non-GAAP financial measure because it allows for the comparison of our operating performance to other REITs and between periods on a consistent basis. Our methodology for calculating Normalized FFO may be different from the methods utilized by other REITS and, accordingly, may not be comparable to such other REITs. Normalized FFO should not be considered as an alternative to net income or loss attributable to controlling interest (computed in accordance with GAAP) as an indicator of our financial performance or to cash flows from operating activities (computed in accordance with GAAP) as an indicator of our liquidity, nor is it indicative of sufficient cash flow to fund our needs. Normalized FFO should be reviewed in connection with other GAAP measurements.

The amounts are generally the same for HTALP and HTA, except for net income or loss attributable to controlling interest, noncontrolling income from partnership units included in diluted shares (only applicable to HTA) and the weighted average number of shares or units outstanding.

The following is the reconciliation of HTA’s FFO and Normalized FFO to net income or loss attributable to controlling interest for the three and nine months ended September 30, 2013 and 2012 (in thousands, except per share data):     

	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
Net income (loss) attributable to controlling interest	$	4,823		$	(2,952	)	$	20,199		$	(22,588	)
Depreciation and amortization expense (including amounts in discontinued operations)	29,581			29,458			87,725			87,779
FFO	$	34,404		$	26,506		$	107,924		$	65,191
FFO per share - basic	$	0.15		$	0.12		$	0.48		$	0.29
FFO per share - diluted	$	0.15		$	0.12		$	0.48		$	0.29
Acquisition-related expenses	1,403			1,341			3,086			6,633
Listing expenses	—			4,751			4,405			17,295
Net (gain) loss on change in fair value of derivative financial instruments	1,955			2,520			(8,573		)	7,815
Noncontrolling income from partnership units included in diluted shares	173			1			384			9
Transitional expenses	—			350			—			2,054
Acceleration of deferred financing costs	—			—			590			415
Escrow settlement revenue	—			—			—			(350		)
Debt extinguishment costs	—			—			—			1,886
Other normalizing items	(4		)	(54		)	(36		)	81
Normalized FFO	$	37,931		$	35,415		$	107,780		$	101,029
Normalized FFO per share - basic	$	0.16		$	0.16		$	0.48		$	0.45
Normalized FFO per share - diluted	$	0.16		$	0.16		$	0.48		$	0.45
Weighted average number of shares outstanding - basic	232,514			218,264			225,132			225,501
Weighted average number of shares outstanding - diluted	235,023			218,420			226,771			225,657

34

The following is the reconciliation of HTLPA’s FFO and Normalized FFO to net income or loss attributable to controlling interest for the three and nine months ended September 30, 2013 and 2012 (in thousands, except per unit data):     

	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
Net income (loss) attributable to controlling interest	$	4,996		$	(2,951	)	$	20,583		$	(22,579	)
Depreciation and amortization expense (including amounts in discontinued operations)	29,581			29,458			87,725			87,779
FFO	$	34,577		$	26,507		$	108,308		$	65,200
FFO per unit - basic	$	0.15		$	0.12		$	0.47		$	0.29
FFO per unit - diluted	$	0.15		$	0.12		$	0.47		$	0.29
Acquisition-related expenses	1,403			1,341			3,086			6,633
Listing expenses	—			4,751			4,405			17,295
Net (gain) loss on change in fair value of derivative financial instruments	1,955			2,520			(8,573		)	7,815
Transitional expenses	—			350			—			2,054
Acceleration of deferred financing costs	—			—			590			415
Escrow settlement revenue	—			—			—			(350		)
Debt extinguishment costs	—			—			—			1,886
Other normalizing items	(4		)	(54		)	(36		)	81
Normalized FFO	$	37,931		$	35,415		$	107,780		$	101,029
Normalized FFO per unit - basic	$	0.16		$	0.16		$	0.47		$	0.44
Normalized FFO per unit - diluted	$	0.16		$	0.16		$	0.47		$	0.44
Weighted average number of units outstanding - basic	235,570			221,413			228,188			227,105
Weighted average number of units outstanding - diluted	235,570			221,413			228,188			227,105

NOI, Cash NOI and Same-Property Cash NOI

NOI is a non-GAAP financial measure that is defined as net income or loss (computed in accordance with GAAP), generated from our total portfolio of properties before general and administrative expenses, non-traded REIT expenses, acquisition-related expenses, depreciation and amortization expense, listing expenses, interest expense and net change in fair value of derivative financial instruments, debt extinguishment costs and other income or expense. We believe that NOI provides an accurate measure of the operating performance of our operating assets because NOI excludes certain items that are not associated with management of the properties. Additionally, we believe that NOI is a widely accepted measure of comparative operating performance in the real estate community. However, our use of the term NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing this amount. NOI should be reviewed in connection with other GAAP measurements.

Cash NOI is a non-GAAP financial measure which excludes from NOI straight-line rent adjustments, amortization of acquired below and above market leases and other non-cash and normalizing items. We believe that Cash NOI provides another measurement of the operating performance of our operating assets. Additionally, we believe that Cash NOI is a widely accepted measure of comparative operating performance of REITs. However, our use of the term Cash NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount. Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance. Cash NOI should be reviewed in connection with other GAAP measurements.

To facilitate the comparison of Cash NOI between periods, we calculate comparable amounts for a subset of our owned properties referred to as “same-property.” Same-property amounts are calculated as the amounts attributable to all properties which have been owned and operated by us during the entire span of all periods reported, excluding properties held for sale. Therefore, any properties acquired after the first day of the earlier comparison period and any real estate notes receivable interest income are excluded from same properties. Same-Property Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance. Same-Property Cash NOI should be reviewed in connection with other GAAP measurements.

35

The following is the reconciliation of HTA’s and HTLPA’s NOI, Cash NOI and Same-Property Cash NOI to net income or loss for the three and nine months ended September 30, 2013 and 2012 (in thousands):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
Net income (loss)	$	5,005		$	(2,931	)	$	20,622		$	(22,551	)
General and administrative expenses	5,980			5,164			18,645			16,079
Non-traded REIT expenses	—			350			—			4,197
Acquisition-related expenses	1,403			1,341			3,086			6,633
Depreciation and amortization expense (including amounts in discontinued operations)	29,581			29,458			87,725			87,779
Listing expenses	—			4,751			4,405			17,295
Interest expense and net change in fair value of derivative financial instruments (including amounts in discontinued operations)	15,188			14,132			30,579			41,097
Debt extinguishment costs	—			—			—			1,886
Other (income) expense	(10		)	24			(28		)	(67		)
NOI	$	57,147		$	52,289		$	165,034		$	152,348
Straight-line rent adjustments, net	(1,565		)	(1,898		)	(4,934		)	(6,462		)
Amortization of acquired below and above market leases, net	506			576			1,576			1,598
Other non-cash and normalizing items	(231		)	(129		)	(513		)	(382		)
Cash NOI	$	55,857		$	50,838		$	161,163		$	147,102
Notes receivable interest income	(562		)	(946		)	(1,654		)	(3,618		)
Non Same-Property Cash NOI	(4,976		)	(1,153		)	(24,677		)	(12,588		)
Same-Property Cash NOI	$	50,319		$	48,739		$	134,832		$	130,896

Liquidity and Capital Resources

We are dependent upon our operating cash flows and the net proceeds from debt and equity to conduct our activities. Our ability to raise funds is dependent on general economic conditions, general market conditions for REITs, and our operating performance. Our total capacity to purchase real estate and other related assets is a function of our current cash position, our borrowing capacity on our unsecured revolving credit facility and from any future indebtedness that we may incur, and any possible future equity offerings. As of September 30, 2013, we had $650.0 million available on our unsecured revolving credit facility. In January 2013, HTA commenced an equity ATM offering of its Class A common stock with an aggregate sales price of up to $250.0 million. During the nine months ended September 30, 2013, approximately 20.7 million shares were issued and sold, at an average price of $11.24 per share. On November 1, 2013, HTA terminated this ATM offering program and commenced a new ATM offering of its Class A common stock with an aggregate sales price of up to $300.0 million. Pursuant to HTALP’s partnership agreement, each time that HTA issues shares of Class A common stock pursuant to an equity offering, HTALP issues to HTA an equal number of partnership units in HTALP and HTA contributes the net proceeds of such offerings to HTALP. In March 2013, we issued $300.0 million of unsecured senior notes bearing interest at 3.70% per annum, payable semi-annually, which were offered at 99.186% of the principal amount thereof.

Our principal demands for funds continues to be for acquisitions of medical office buildings and other facilities that serve the healthcare industry, to pay operating expenses and principal and interest on our outstanding debt, and to pay dividends to our stockholders.

Generally, cash needs for items other than acquisitions of medical office buildings and other facilities that serve the healthcare industry continue to be met from operations and borrowings. We believe that these cash resources will be sufficient to satisfy our cash requirements for the foreseeable future, including our requirements to meet our debt maturities coming due during the year ending December 31, 2013.

36

When we acquire a property, we prepare a capital plan that contemplates the estimated capital needs of that investment. In addition to operating expenses, capital needs may also include costs of refurbishment, tenant improvements or other major capital expenditures. The capital plan also sets forth the anticipated sources of the necessary capital, which may include a credit facility or other loan established with respect to the investment, operating cash generated by the investment, additional equity investments from us or joint venture partners or, when necessary, capital reserves. Any capital reserve would be established from the net proceeds from sales of other investments, operating cash generated by other investments, or other cash on hand. In some cases, a lender may require us to establish capital reserves for a particular investment. The capital plan for each investment will be adjusted through ongoing, regular reviews of our portfolio or as necessary to respond to unanticipated additional capital needs.

Other Liquidity Needs

In the event that there is a shortfall in net cash available due to various factors, including, without limitation, the timing of dividends or the timing of the collections of receivables, we may seek to obtain capital to pay dividends by means of secured or unsecured debt financing through one or more third parties or through offering proceeds. We may also pay dividends from cash from capital transactions, including, without limitation, the sale of one or more of our properties.

As of September 30, 2013, we estimate that our expenditures for capital improvements for the remaining three months of 2013 will range from approximately $4.0 million to $6.0 million depending on leasing activity. As of September 30, 2013, we had $10.0 million of restricted cash in loan impounds and reserve accounts for such capital expenditures. We cannot provide assurance, however, that we will not exceed these estimated expenditure levels or be able to obtain additional sources of financing on commercially favorable terms or at all. As of September 30, 2013, we had $1.7 million of debt maturing during the last three months of the year. We will use cash flows from operations, cash on hand, our unsecured revolving credit facility, and any possible future debt or equity offerings to fund these debt maturities. As of September 30, 2013, we had cash and cash equivalents of $82.2 million and $650.0 million available on our unsecured revolving credit facility. Additionally, as of September 30, 2013, we had unencumbered properties with a gross book value of approximately $2.1 billion that may be used as collateral to secure additional financings in future periods or as additional collateral to facilitate the refinancing of current debt as it becomes due.

If we experience lower occupancy levels, reduced rental rates, reduced revenues as a result of asset sales, or increased capital expenditures and leasing costs compared to historical levels due to competitive market conditions for new and renewal leases, the effect would be a reduction of net cash provided by operating activities. If such a reduction of net cash provided by operating activities is realized, we may have a cash flow deficit in subsequent periods. Our estimate of net cash available is based on various assumptions which are difficult to predict, including the levels of leasing activity and related leasing costs. Any changes in these assumptions could impact our financial results and our ability to fund working capital and unanticipated cash needs.

Cash Flows

The following is a summary of our cash flows for the nine months ended September 30, 2013 and 2012 (in thousands):

	Nine Months Ended September 30,
	2013			2012			Change
Cash and cash equivalents - beginning of period	$	15,956		$	69,491		$	(53,535	)
Net cash provided by operating activities	118,675			83,803			34,872
Net cash used in investing activities	(251,291		)	(252,237		)	946
Net cash provided by financing activities	198,841			107,283			91,558
Cash and cash equivalents - end of period	$	82,181		$	8,340		$	73,841

Net cash provided by operating activities increased in 2013 primarily due to the $268.7 million of completed acquisitions since September 30, 2012 and the costs incurred in 2012 associated with the Listing. We anticipate cash flows from operating activities to increase with contractual rent increases and continued leasing activity in our existing portfolio and as we continue to acquire more properties.

For the nine months ended September 30, 2013, net cash used in investing activities primarily related to the acquisition of real estate operating properties and other assets of $223.8 million and capital expenditures of $16.5 million. For the nine months ended September 30, 2012, net cash used in investing activities primarily related to the acquisition of real estate operating properties and other assets of $230.6 million and capital expenditures of $18.3 million. We anticipate cash flows used in investing activities to increase as we purchase more properties.

37

For the nine months ended September 30, 2013, net cash provided by financing activities primarily related to net proceeds from the issuance of unsecured senior notes of $297.6 million and from the net proceeds of shares of Class A common stock issued through the ATM of $229.5 million, partially offset by payments on our secured real estate term loan and mortgage loans of $155.3 million, net payments on our unsecured revolving credit facility of $72.0 million, and dividends to our common stockholders of $95.6 million. For the nine months ended September 30, 2012, net cash provided by financing activities primarily related to borrowings on our unsecured term loan of $455.0 million, partially offset by payment on our mortgage loans of $106.5 million, dividends to our common stockholders of $62.5 million, and repurchase of common stock of $182.4 million.

Dividends

The amount of dividends HTA pays to its stockholders is determined by its Board of Directors, at its sole discretion, and is dependent on a number of factors, including funds available, our financial condition, capital expenditure requirements and annual dividend distribution requirements needed to maintain our status as a REIT under the Internal Revenue Code of 1986, as amended. HTA has paid dividends monthly or quarterly since February 2007 and if our investments produce sufficient cash flow, we expect to continue to pay dividends to our stockholders. Because our cash available for dividend distributions in any year may be less than 90% of our taxable income for the year, we may obtain the necessary funds by borrowing, issuing new securities or selling assets to pay out enough of our taxable income to satisfy the dividend distribution requirement. HTA’s organizational documents do not establish a limit on dividends that may constitute a return of capital for federal income tax purposes. The dividend HTA pays to its stockholders is equal to the distributions received from HTALP according to the terms of HTALP’s partnership agreement.

In May 2012, HTA’s Board of Directors determined that it was in the best interest of our stockholders to pay quarterly dividends at an annualized rate of $0.575 per share. It is HTA’s intent to continue to pay dividends. However, our Board of Directors may reduce our dividend rate and HTA cannot guarantee the timing and amount of dividends paid in the future, if any.

For the nine months ended September 30, 2013, HTA paid cash dividends of $95.6 million. On October 4, 2013, HTA paid cash dividends of $33.9 million holders of Class A and B common stock for the quarter ending September 30, 2013. On November 4, 2013, HTA’s Board of Directors authorized a quarterly cash dividend to be paid on January 3, 2014 to stockholders of record on December 27, 2013. This dividend of $0.14375 per share will be paid on both Class A and B common stock of HTA.

Financing

We anticipate that our aggregate borrowings, both secured and unsecured, will approximate between 35% and 45% of all of our properties’ and real estate notes receivables’ combined values, as determined at the end of each calendar year. For these purposes, the value of each asset will be equal to the purchase price paid for the asset or, if the asset was appraised subsequent to the date of purchase, then the value will be equal to the value reported in the most recent independent appraisal of the asset. Our policies do not limit the amount we may borrow with respect to any individual investment. As of September 30, 2013, our leverage ratio of total debt to total capitalization was 31.0%.

As of September 30, 2013, we had net debt outstanding of $1.1 billion and the weighted average interest rate inclusive of the impact of our interest rate swaps, was 4.16% per annum. The following is a summary of our unsecured and secured debt. See Note 8, Debt, to our accompanying condensed consolidated financial statements, for a further discussion of our debt.

Unsecured Revolving Credit Facility

In March 2013, we executed an amendment to our unsecured revolving credit agreement pursuant to an existing provision and increased the amount available under our unsecured revolving credit facility by $75.0 million to $650.0 million. As of September 30, 2013, $650.0 million was available on the unsecured revolving credit facility. The unsecured revolving credit facility matures in March 2016 and includes a one-year extension, subject to certain conditions.

Unsecured Term Loans

As of September 30, 2013, we had $455.0 million of unsecured term loans outstanding, of which $300.0 million matures in March 2016 and $155.0 million matures in July 2019. The amount maturing in March 2016 includes a one-year extension, subject to certain conditions.

Unsecured Senior Notes

In March 2013, we issued $300.0 million of unsecured senior notes that mature in April 2023. The $300.0 million of unsecured senior notes bear interest at 3.70% per annum, payable semi-annually, and were offered at 99.186% of the principal amount thereof.

38

Secured Real Estate Term Loan and Mortgage Loans

In March 2013, we repaid in full and terminated our $125.5 million secured real estate term loan. During the nine months ended September 30, 2013, we made principal payments of $29.8 million on our mortgage loans and we have $1.7 million of principal payments due the last three months of 2013. In September 2013, we assumed $18.0 million of mortgage loans as part of an acquisition.

Critical Accounting Policies

The complete listing of our Critical Accounting Policies was previously disclosed in our 2012 Annual Report on Form 10-K for HTA and Registration Statement on Form S-4 for HTALP, as amended, that was declared effective by the SEC on October 22, 2013 (File No. 333-190916). There have been no material changes to our Critical Accounting Policies as disclosed therein.

Interim Unaudited Financial Data

Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim period. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2012 Annual Report on Form 10-K for HTA and Registration Statement on Form S-4 for HTALP, as amended, that was declared effective by the SEC on October 22, 2013 (File No. 333-190916).

Recently Issued or Adopted Accounting Pronouncements

See Note 2, Summary of Significant Accounting Policies - Recently Issued or Adopted Accounting Pronouncements, to our accompanying condensed consolidated financial statements, for a discussion of recently issued or adopted accounting pronouncements.

Commitments and Contingencies

See Note 10, Commitments and Contingencies, to our accompanying condensed consolidated financial statements, for a further discussion of our commitments and contingencies.

Debt Service Requirements

We are required by the terms of the applicable loan documents to meet certain financial covenants, such as minimum net worth and liquidity, and reporting requirements. As of September 30, 2013, we believe that we were in compliance with all such covenants and reporting requirements on our debt.

Off-Balance Sheet Arrangements

As of and during the nine months ended September 30, 2013, we had no off-balance sheet arrangements.

Inflation

We are exposed to inflation risk as income from future long-term leases is the primary source of our cash flows from operations. There are provisions in the majority of our tenant leases that protect us from the impact of normal inflation. These provisions include rent escalations, reimbursement billings for operating expense pass-through charges, real estate tax and insurance reimbursements on a per square foot allowance. However, due to the long-term nature of the leases, among other factors, the leases may not re-set frequently enough to cover inflation.

39

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There were no material changes in the information regarding market risk that was provided in our 2012 Annual Report on Form 10-K for HTA and Registration Statement on Form S-4 for HTALP, as amended, that was declared effective by the SEC on October 22, 2013 (File No. 333-190916).

The table below presents, as of September 30, 2013, the principal amounts of our fixed and variable debt and the weighted average interest rates excluding the impact of interest rate swaps by year of expected maturity to evaluate the expected cash flows and sensitivity to interest rate changes (in thousands, except interest rates):

	Expected Maturity Date
	2013			2014			2015			2016			2017			Thereafter			Total
Fixed rate debt	$	1,722		$	6,872		$	73,128		$	121,578		$	99,963		$	367,373		$	670,636
Weighted average interest rate on fixed rate debt (per annum)	5.46		%	5.40		%	5.38		%	5.15		%	5.91		%	4.20		%	4.90		%
Variable rate debt	$	—		$	—		$	—		$	300,000		$	—		$	155,000		$	455,000
Weighted average interest rate on variable rate debt based on forward rates in effect as of September 30, 2013 (per annum)	—		%	—		%	—		%	3.82		%	—		%	5.32		%	3.07		%

Our total debt was $1.1 billion (excluding net discount) as of September 30, 2013. We had fixed and variable rate debt with interest rates ranging from 2.03% to 12.75% per annum and a weighted average interest rate of 3.76% per annum as of September 30, 2013. We had $670.6 million (excluding net discount) of fixed rate debt, or 59.6% of total debt, at a weighted average interest rate of 4.90% per annum and $455.0 million of variable rate debt, or 40.4% of total debt, at a weighted average interest rate of 2.08% per annum as of September 30, 2013.

As of September 30, 2013, the fair value of our fixed rate debt was $692.9 million and the fair value of our variable rate debt was $456.5 million based upon prevailing market rates as of September 30, 2013.

As of September 30, 2013, we had interest rate swaps outstanding that effectively fix $455.0 million of variable rate debt. Including the impact of these interest rate swaps, the effective rate on our variable rate debt is 3.07% per annum.

In addition to changes in interest rates, the value of our future properties is subject to fluctuations based on changes in local and regional economic conditions and changes in the creditworthiness of tenants, which may affect our ability to refinance our debt if necessary.

40

Item 4. Controls and Procedures

Healthcare Trust of America, Inc. (“HTA”)

HTA’s management is responsible for establishing and maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to its management, including HTA’s Chief Executive Officer and Chief Financial Officer, who serve as our principal financial officer and principal accounting officer, as appropriate, to allow timely decisions regarding required disclosure.

As of September 30, 2013, an evaluation was conducted by HTA under the supervision and with the participation of its management, including HTA’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that HTA’s disclosure controls and procedures were effective.

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2013 that have materially affected, or are reasonably likely to materially affect, HTA’s internal control over financial reporting.

Healthcare Trust of America Holdings, LP (“HTALP”)

HTALP’s management is responsible for establishing and maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to its management, including HTA’s Chief Executive Officer and Chief Financial Officer, who serve as our principal financial officer and principal accounting officer, as appropriate, to allow timely decisions regarding required disclosure.

As of September 30, 2013, an evaluation was conducted by HTALP under the supervision and with the participation of its management, including HTA’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, HTA’s Chief Executive Officer and the Chief Financial Officer, on behalf of HTA in its capacity as general partner of HTALP, concluded that HTALP’s disclosure controls and procedures were effective.

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2013 that have materially affected, or are reasonably likely to materially affect, HTALP’s internal control over financial reporting.

41

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may be involved in various claims and legal actions arising in the ordinary course of business. As of September 30, 2013, we were not involved in any material legal proceedings.

Item 1A. Risk Factors

There are no material changes from the risk factors previously disclosed in our 2012 Annual Report on Form 10-K for HTA and Registration Statement on Form S-4 for HTALP, as amended, that was declared effective by the SEC on October 22, 2013 (File No. 333-190916).

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

During the three months ended September 30, 2013, HTA repurchased shares of its common stock as follows:

Period	Total Number of Shares Purchased (1)	Average Price Paid per Share (1)		Total Number of Shares Purchased as Part of Publicly Announced Plan or Program	Maximum Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs
July 1, 2013 to July 31, 2013	—	$	—	—	(2	)
August 1, 2013 to August 31, 2013	—	—		—	(2	)
September 1, 2013 to September 30, 2013	1,573	10.30		—	(2	)

____________________

(1) Purchases represent shares withheld to satisfy withholding obligations on the vesting of restricted shares. The price paid per share was the closing price of our Class A common stock on the NYSE.

(2) On August 6, 2012, our Board of Directors approved a stock repurchase program of up to $100.0 million of our Class A common stock from time to time prior to August 5, 2014. There have been no repurchases under this program and $100.0 million of repurchase capacity remains available under this program.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

The exhibits listed on the Exhibit Index (following the signatures section of this Quarterly Report on Form 10-Q) are included, and incorporated by reference, in this Quarterly Report on Form 10-Q.

42

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		HEALTHCARE TRUST OF AMERICA, INC.
Date:	November 5, 2013	By:	/s/  Scott D. Peters
			Scott D. Peters
			Chief Executive Officer, President and Chairman
			(Principal Executive Officer)
Date:	November 5, 2013	By:	/s/  Kellie S. Pruitt
			Kellie S. Pruitt
			Chief Financial Officer
			(Principal Financial Officer and Principal Accounting Officer)

		HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
		By:	HEALTHCARE TRUST OF AMERICA, INC.,
			its General Partner
Date:	November 5, 2013	By:	/s/  Scott D. Peters
			Scott D. Peters
			Chief Executive Officer, President and Chairman
			(Principal Executive Officer)
Date:	November 5, 2013	By:	/s/  Kellie S. Pruitt
			Kellie S. Pruitt
			Chief Financial Officer
			(Principal Financial Officer and Principal Accounting Officer)

43

EXHIBIT INDEX

Following the consummation of the merger of NNN Realty Advisors, Inc., which previously served as our sponsor, with and into a wholly owned subsidiary of Grubb & Ellis Company on December 7, 2007, NNN Healthcare/Office REIT, Inc., NNN Healthcare/Office REIT Holdings, L.P., NNN Healthcare/Office REIT Advisor, LLC and NNN Healthcare/Office Management, LLC changed their names to Grubb & Ellis Healthcare REIT, Inc., Grubb & Ellis Healthcare REIT Holdings, LP, Grubb & Ellis Healthcare REIT Advisor, LLC, and Grubb & Ellis Healthcare Management, LLC, respectively.

Following the Registrant’s transition to self-management, on August 24, 2009, Grubb & Ellis Healthcare REIT, Inc. and Grubb & Ellis Healthcare REIT Holdings, LP changed their names to Healthcare Trust of America, Inc. and Healthcare Trust of America Holdings, LP, respectively.

The following Exhibit List refers to the entity names used prior to such name changes in order to accurately reflect the names of the parties on the documents listed.

Pursuant to Item 601(a)(2) of Regulation S-K, this Exhibit Index immediately precedes the exhibits.

The following exhibits are included, or incorporated by reference, in this Quarterly Report on Form 10-Q for the period ended September 30, 2013 (and are numbered in accordance with Item 601 of Regulation S-K).

31.1*	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America, Inc.
31.2*	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America, Inc.
31.3*	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America Holdings, LP.
31.4*	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America Holdings, LP.
32.1**	Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America, Inc.
32.2**	Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America, Inc.
32.3**	Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America Holdings, LP.
32.4**	Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America Holdings, LP.
101.INS*	XBRL Instance Document.
101.SCH*	XBRL Taxonomy Extension Schema Document.
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document.
*	Filed herewith.
**	Furnished herewith.

44

EX-31.1

Exhibit 31.1

CERTIFICATION

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Scott D. Peters, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Trust of America, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ Scott D. Peters
	Scott D. Peters
	Chief Executive Officer, President and Chairman

Date: November 5, 2013

EX-31.2

Exhibit 31.2

CERTIFICATION

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Kellie S. Pruitt, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Trust of America, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ Kellie S. Pruitt
	Kellie S. Pruitt
	Chief Financial Officer

Date: November 5, 2013

EX-31.3

Exhibit 31.3

CERTIFICATION

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Scott D. Peters, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Trust of America Holdings, LP;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ Scott D. Peters
	Scott D. Peters
	Chief Executive Officer, President and Chairman of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP

Date: November 5, 2013

EX-31.4

Exhibit 31.4

CERTIFICATION

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Kellie S. Pruitt, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Trust of America Holdings, LP;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ Kellie S. Pruitt
	Kellie S. Pruitt
	Chief Financial Officer of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP

Date: November 5, 2013

EX-32.1

Exhibit 32.1

CERTIFICATION

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Healthcare Trust of America, Inc., or the Company, for the period ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Scott D. Peters, Chief Executive Officer, President and Chairman of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(i) the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Scott D. Peters
	Scott D. Peters
	Chief Executive Officer, President and Chairman

Date: November 5, 2013

EX-32.2

Exhibit 32.2

CERTIFICATION

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Healthcare Trust of America, Inc., or the Company, for the period ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Kellie S. Pruitt, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(i) the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Kellie S. Pruitt
	Kellie S. Pruitt
	Chief Financial Officer

Date: November 5, 2013

EX-32.3

Exhibit 32.3

CERTIFICATION

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Healthcare Trust of America Holdings, LP, or the Company, for the period ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Scott D. Peters, Chief Executive Officer, President and Chairman of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(i) the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Scott D. Peters
	Scott D. Peters
	Chief Executive Officer, President and Chairman of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP

Date: November 5, 2013

EX-32.4

Exhibit 32.4

CERTIFICATION

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Healthcare Trust of America Holdings, LP, or the Company, for the period ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Kellie S. Pruitt, Chief Financial Officer of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(i) the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Kellie S. Pruitt
	Kellie S. Pruitt
	Chief Financial Officer of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP

Date: November 5, 2013

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2013

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Litigation

We are not presently subject to any material litigation nor, to our knowledge, is any material litigation threatened against us, which if determined unfavorably to us, would have a material effect on our condensed consolidated financial position, results of operations or cash flows.

Environmental Matters

We follow the policy of monitoring our properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at our properties, we are not currently aware of any environmental liability with respect to our properties that would have a material effect on our condensed consolidated financial position, results of operations or cash flows. Further, we are not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability at our properties that we believe would require additional disclosure or the recording of a loss contingency.

Other

Our other commitments and contingencies include the usual obligations of real estate owners and operators in the normal course of business. In our opinion, these matters are not expected to have a material effect on our condensed consolidated financial position, results of operations or cash flows.

XML

Stockholders' Equity and Partners' Capital - Nonvested Rollforward (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Long Term Incentive Program
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Balance as of December 31, 2012 (in shares)	2,900,000
Granted (in shares)	0
Vested (in shares)	(2,380,700)
Forfeited (in shares)	(2,100)
Balance as of September 30, 2013 (in shares)	517,200.0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Balance as of December 31, 2012, Weighted Average Grant Date Fair Value (usd per share)	$ 6.25
Granted, Weighted Average Grant Date Fair Value (usd per share)	$ 0.00
Vested, Weighted Average Grant Date Fair Value (usd per share)	$ 5.56
Forfeited, Weighted Average Grant Date Fair Value (usd per share)	$ 5.62
Balance as of September 30, 2013, Weighted Average Grant Date Fair Value (usd per share)	$ 9.42
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Balance as of December 31, 2012 (in shares)	376,500
Granted (in shares)	475,500
Vested (in shares)	(92,500)
Forfeited (in shares)	(63,500)
Balance as of September 30, 2013 (in shares)	696,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Balance as of December 31, 2012, Weighted Average Grant Date Fair Value (usd per share)	$ 9.98
Granted, Weighted Average Grant Date Fair Value (usd per share)	$ 10.56
Vested, Weighted Average Grant Date Fair Value (usd per share)	$ 10.10
Forfeited, Weighted Average Grant Date Fair Value (usd per share)	$ 10.00
Balance as of September 30, 2013, Weighted Average Grant Date Fair Value (usd per share)	$ 10.35

XML

Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues:
Rental income	$ 81,906	$ 76,465	$ 234,338	$ 220,222
Interest income from real estate notes receivable and other income	635	1,067	1,874	3,683
Total revenues	82,541	77,532	236,212	223,905
Expenses:
Rental	25,774	25,744	72,235	73,038
General and administrative	5,980	5,164	18,645	16,079
Non-traded REIT	0	350	0	4,197
Acquisition-related	1,403	1,341	3,086	6,633
Depreciation and amortization	29,581	29,228	87,554	87,091
Listing	0	4,751	4,405	17,295
Total expenses	62,738	66,578	185,925	204,333
Income (loss) before other income (expense)	19,803	10,954	50,287	19,572
Interest expense:
Interest related to debt	(12,146)	(10,172)	(35,543)	(30,648)
Interest related to derivative financial instruments and net change in fair value of derivative financial instruments	(3,042)	(3,832)	5,125	(10,066)
Debt extinguishment costs	0	0	0	(1,886)
Other income (expense)	10	(24)	28	67
Income (loss) from continuing operations	4,625	(3,074)	19,897	(22,961)
Income from discontinued operations	380	143	725	410
Net income (loss)	5,005	(2,931)	20,622	(22,551)
Net income attributable to noncontrolling interests	(182)	(21)	(423)	(37)
Net income (loss) attributable to controlling interest	4,823	(2,952)	20,199	(22,588)
Earnings (losses) per share/unit attributable to controlling interest - basic:
Continuing operations (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Discontinued operations (usd per share/unit)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net income (loss) (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Earnings (losses) per share/unit attributable to controlling interest - diluted:
Continuing operations (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Discontinued operations (usd per share/unit)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net income (loss) (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Weighted average number of shares/units outstanding:
Basic (in shares/units)	232,514	218,264	225,132	225,501
Diluted (in shares/units)	235,023	218,264	226,771	225,501
Dividends declared per common share (usd per share/unit)	$ 0.14	$ 0.14	$ 0.43	$ 0.49
Healthcare Trust of America Holdings, LP (HTALP)
Revenues:
Rental income	81,906	76,465	234,338	220,222
Interest income from real estate notes receivable and other income	635	1,067	1,874	3,683
Total revenues	82,541	77,532	236,212	223,905
Expenses:
Rental	25,774	25,744	72,235	73,038
General and administrative	5,980	5,164	18,645	16,079
Non-traded REIT	0	350	0	4,197
Acquisition-related	1,403	1,341	3,086	6,633
Depreciation and amortization	29,581	29,228	87,554	87,091
Listing	0	4,751	4,405	17,295
Total expenses	62,738	66,578	185,925	204,333
Income (loss) before other income (expense)	19,803	10,954	50,287	19,572
Interest expense:
Interest related to debt	(12,146)	(10,172)	(35,543)	(30,648)
Interest related to derivative financial instruments and net change in fair value of derivative financial instruments	(3,042)	(3,832)	5,125	(10,066)
Debt extinguishment costs	0	0	0	(1,886)
Other income (expense)	10	(24)	28	67
Income (loss) from continuing operations	4,625	(3,074)	19,897	(22,961)
Income from discontinued operations	380	143	725	410
Net income (loss)	5,005	(2,931)	20,622	(22,551)
Net income attributable to noncontrolling interests	(9)	(20)	(39)	(28)
Net income (loss) attributable to controlling interest	$ 4,996	$ (2,951)	$ 20,583	$ (22,579)
Earnings (losses) per share/unit attributable to controlling interest - basic:
Continuing operations (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Discontinued operations (usd per share/unit)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net income (loss) (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Earnings (losses) per share/unit attributable to controlling interest - diluted:
Continuing operations (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Discontinued operations (usd per share/unit)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net income (loss) (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Weighted average number of shares/units outstanding:
Basic (in shares/units)	235,570	221,413	228,188	227,105
Diluted (in shares/units)	235,570	221,413	228,188	227,105
Dividends declared per common share (usd per share/unit)	$ 0.14	$ 0.14	$ 0.43	$ 0.49

XML

Business Combinations

9 Months Ended

Sep. 30, 2013

Business Combinations [Abstract]

Business Combinations

Business Combinations

For the nine months ended September 30, 2013, we have completed seven acquisitions for an aggregate purchase price of $241.9 million, in addition to closing costs attributable to these acquisitions of $1.4 million. Results of operations for these acquisitions are reflected in our condensed consolidated statements of operations for the three and nine months ended September 30, 2013, for the periods subsequent to the acquisition dates.

The aggregate net purchase price of the 2013 acquisitions was allocated in the amounts set forth in the table below. Due to the recent timing of certain acquisitions, we have not yet finalized our purchase price allocation. Since the acquisitions were determined to be individually not significant, but material on a collective basis, the allocations for these acquisitions are set forth below in the aggregate (in thousands):

2013 Acquisitions	Total
Land	$	13,415
Building and improvements	175,039
Below market leasehold interests	1,836
Above market leases	1,987
In place leases	32,205
Tenant relationships	16,541
Below market leases	(1,167		)
Above market debt	(241		)
Net assets acquired	239,615
Other, net	2,299
Aggregate purchase price	$	241,914

The weighted average lives of the above acquired intangible assets and liabilities were 7.4 years and 5.7 years, respectively.

The property acquisitions completed during the nine months ended September 30, 2013, were all cash transactions except for the acquisition on September 20, 2013 and we acquired a 100% ownership interest in each property acquisition. See below for a brief description of each of the acquisitions.

• On March 11, 2013, we completed the acquisition of a medical office building located in Dallas, Texas for $48.7 million.

• On March 22, 2013, we completed the acquisition of a medical office building located in Bryan - College Station, Texas for $39.8 million.

• On June 18, 2013, we completed the acquisition of a medical office building located in Atlanta, Georgia for $5.6 million.

• On July 12, 2013, we completed the acquisition of a medical office property located in Monroeville, Pennsylvania for $15.1 million.

• On July 29, 2013, we completed the acquisition of a medical office building located in Denver, Colorado for $42.0 million.

• On August 30, 2013, we completed the acquisition of a medical office building located in Dallas, Texas for $27.7 million.

• On September 20, 2013, we completed the acquisition of a portfolio of medical office buildings located in South Florida for $62.9 million. As part of the acquisition, we assumed approximately $18.0 million of mortgage loans.

In addition, we have entered into two definitive purchase agreements for the acquisition of medical office buildings located in Austin, Texas totaling approximately $30.0 million. The closing of these acquisitions are subject to the satisfaction of customary closing conditions.

The aggregate net purchase price of the 2012 acquisitions was allocated in the amounts set forth in the table below. Since the acquisitions were determined to be individually not significant, but material on a collective basis, the allocations for these acquisitions are set forth below in the aggregate (in thousands):

2012 Acquisitions	Total
Land	$	3,809
Building and improvements	214,772
Below market leasehold interests	3,284
Above market leases	4,199
In place leases	23,388
Tenant relationships	19,863
Below market leases	(1,415		)
Net assets acquired	267,900
Other, net	287
Aggregate purchase price	$	268,187

The weighted average lives of the above acquired intangible assets and liabilities were 14.8 years and 7.5 years, respectively.

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Schedule of Reclassifications

The following table presents the previously reported balances of and the reclassified balances for the impacted line items of the December 31, 2012 balance sheet (in thousands):

	December 31, 2012
	As Previously Reported		As Reclassified
Real estate investments:
Land	$	—	$	183,651
Building and improvements	—		2,044,113
Lease intangibles	—		352,884
	—		2,580,648
Accumulated depreciation and amortization	—		(349,118		)
Real estate investments, net	1,992,607		2,231,530
Accounts and other receivables, net	13,317		—
Receivables and other assets, net	71,653		84,970
Other intangibles, net	282,934		44,011

XML

Fair Value of Financial Instruments (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Real estate notes receivable	$ 28,520	$ 20,000
Tenant note receivable	3,202	3,287
Debt, net	1,125,792	1,037,359
Carrying Amount | Fair Value Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Real estate notes receivable	28,520	20,000
Tenant note receivable	3,202	3,287
Debt, net	1,125,792	1,037,359
Fair Value | Fair Value Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Real estate notes receivable	28,520	20,000
Tenant note receivable	3,098	3,337
Debt, net	$ 1,149,460	$ 1,087,168

XML

Stockholders' Equity and Partners' Capital

9 Months Ended

Sep. 30, 2013

Equity [Abstract]

Stockholders' Equity and Partners' Capital

Stockholders’ Equity and Partners’ Capital

HTALP’s partnership agreement provides that it will distribute cash flows from operations and net sale proceeds to its partners in accordance with their overall ownership interests at such times and in such amounts as the general partner determines. Except for certain LTIP units that have not vested, dividend distributions are made such that a holder of one unit will receive annual dividend distributions from HTALP in an amount equal to the annual dividends paid to the holder of one of HTA’s shares. In addition, for each share of common stock issued or redeemed by HTA, HTALP issues or redeems a corresponding number of units.

Common Stock Offerings

On January 7, 2013, HTA commenced an equity at-the-market, or ATM, offering of its Class A common stock with an aggregate sales price of up to $250.0 million. During the nine months ended September 30, 2013, HTA issued and sold 20,707,113 shares, at an average price of $11.24 per share. On November 1, 2013, HTA terminated this ATM offering and commenced a new ATM offering of its Class A common stock with an aggregate sales price of up to $300.0 million.

Common Stock Dividends

The following are the cash dividends declared by HTA on all Class A and B common stock during 2013:

Declaration Date	Record Date	Amount Per Share		Payment Date
January 18, 2013	March 29, 2013	$	0.14375	April 4, 2013
April 26, 2013	June 27, 2013	0.14375		July 3, 2013
August 1, 2013	September 27, 2013	0.14375		October 4, 2013
November 4, 2013	December 27, 2013	0.14375		January 3, 2014

Incentive Plan

Our Amended and Restated 2006 Plan, or the Plan, permits the grant of incentive awards to our employees, officers, non-employee directors, and consultants as selected by our Board of Directors or the Compensation Committee. The Plan authorizes the granting of awards in any of the following forms: options; stock appreciation rights; restricted stock; restricted or deferred stock units; performance awards; dividend equivalents; other stock-based awards, including units in HTALP; and cash-based awards. The service period is generally three or four years. Subject to adjustment as provided in the Plan, the aggregate number of awards reserved and available for issuance under the Plan is 10,000,000. As of September 30, 2013, there were 5,096,100 awards available for grant under the Plan.

Long Term Incentive Program of OP Units

Awards under the LTIP consist of Series C units in HTALP, and are subject to the achievement of certain performance and market conditions in order to vest. Once vested, the Series C units are converted into common units of HTALP, which may be converted into shares ofHTA’scommon stock.

For thethree and nine months ended September 30, 2013, we recognized compensation expense related to LTIP awards of$0.0 million and $3.1 million, respectively, which was recorded in listing expenses. For thethree and nine months ended September 30, 2012, we recognized compensation expense related to LTIP awards of$4.5 millionand$5.9 million, respectively, which was recorded in listing expenses. As ofSeptember 30, 2013, there was approximately$4.5 millionof unrecognized expense associated with450,000units that will only vest as a result of a change in control. We will not recognize any expense associated with these units until such event occurs or is probable.

The following is a summary of the activity in our LTIP units during 2013:

	LTIP Units		Weighted Average Grant Date Fair Value
Balance as of December 31, 2012	2,900,000		$	6.25
Granted	—		—
Vested	(2,380,700	)	5.56
Forfeited	(2,100	)	5.62
Balance as of September 30, 2013	517,200		$	9.42

Restricted Common Stock

For the three months ended September 30, 2013, we recognized compensation expense of $0.5 million, which was recorded in general and administrative expenses. For the nine months ended September 30, 2013, we recognized compensation expense of $2.0 million, of which $1.4 million was recorded in general and administrative expenses and $0.6 million was recorded in listing expenses. For the three months ended September 30, 2012, we recognized compensation expense of $0.2 million, which was recorded in general and administrative expenses. For the nine months ended September 30, 2012, we recognized compensation expense of $6.4 million, of which $0.2 million was recorded in general and administrative expenses, $4.7 million was recorded in listing expenses, and $1.5 million was recorded in non-traded REIT expenses.

As of September 30, 2013, there was approximately $4.2 million of unrecognized compensation expense net of estimated forfeitures, related to nonvested shares of restricted common stock which will be recognized over a remaining weighted average period of 2.3 years.

The following is a summary of the activity in our restricted common stock during 2013:

	Restricted Common Stock		Weighted Average Grant Date Fair Value
Balance as of December 31, 2012	376,500		$	9.98
Granted	475,500		10.56
Vested	(92,500	)	10.10
Forfeited	(63,500	)	10.00
Balance as of September 30, 2013	696,000		$	10.35

XML

Derivative Financial Instruments - Table of Derivative Financial Instruments (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Derivative
Fair value, asset	$ 3,656	$ 0
Fair value, liability	(3,258)	(9,370)
Interest Rate Swap | 3.79%
Derivative
Notional amount		17,304	[1]
Index		LIBOR	[1]
Interest Rate		3.79%	[1]
Fair value, liability		(459)	[1]
Interest Rate Swap | 1.07%
Derivative
Notional amount		75,000	[1]
Index		LIBOR	[1]
Interest Rate		1.07%	[1]
Fair value, liability		(659)	[1]
Interest Rate Swap | 1.23%
Derivative
Notional amount	200,000	200,000
Index	LIBOR	LIBOR
Interest Rate	1.23%	1.23%
Fair value, liability	(2,490)	(5,180)
Interest Rate Swap | 0.86%
Derivative
Notional amount	100,000	100,000
Index	LIBOR	LIBOR
Interest Rate	0.86%	0.86%
Fair value, liability	(768)	(1,310)
Interest Rate Swap | 1.39%
Derivative
Notional amount	50,000	50,000
Index	LIBOR	LIBOR
Interest Rate	1.39%	1.39%
Fair value, asset	882
Fair value, liability		(909)
Interest Rate Swap | 1.24%
Derivative
Notional amount	105,000	105,000
Index	LIBOR	LIBOR
Interest Rate	1.24%	1.24%
Fair value, asset	2,774
Fair value, liability		$ (853)

[1] We terminated the interest rate swaps in March 2013.

XML

Per Share Data (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Earnings Per Share [Abstract]
Number anti-diluted shares outstanding adjustment (in shares)		156		156
Numerator:
Income (loss) from continuing operations attributable to controlling interest	$ 4,443	$ (3,095)	$ 19,474	$ (22,998)
Discontinued operations	380	143	725	410
Net income (loss) attributable to controlling interest	$ 4,823	$ (2,952)	$ 20,199	$ (22,588)
Denominator:
Weighted average number of shares outstanding — basic (in shares/units)	232,514	218,264	225,132	225,501
Dilutive shares (in shares/units)	2,509	0	1,639	0
Weighted average number of shares outstanding — diluted (in shares/units)	235,023	218,264	226,771	225,501
Earnings (losses) per share attributable to controlling interest - basic:
Continuing operations (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Discontinued operations (usd per share/unit)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net income (loss) (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Earnings (losses) per share attributable to controlling interest - diluted:
Continuing operations (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Discontinued operations (usd per share/unit)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net income (loss) (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)

XML

Summary of Significant Accounting Policies - Reclassifications (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Real estate investments:
Land	$ 195,115	$ 183,651
Building and improvements	2,215,513	2,044,113
Lease intangibles	386,801	352,884
Real estate investments, gross	2,818,567	2,580,648
Accumulated depreciation and amortization	(415,615)	(349,118)
Real estate investments, net	2,402,952	2,231,530
Accounts and other receivables, net	19,595	13,317
Receivables and other assets, net	104,996	84,970
Other intangibles, net	41,794	44,011
As Previously Reported
Real estate investments:
Land		0
Building and improvements		0
Lease intangibles		0
Real estate investments, gross		0
Accumulated depreciation and amortization		0
Real estate investments, net		1,992,607
Accounts and other receivables, net		13,317
Receivables and other assets, net		71,653
Other intangibles, net		282,934
As Reclassified
Real estate investments:
Land		183,651
Building and improvements		2,044,113
Lease intangibles		352,884
Real estate investments, gross		2,580,648
Accumulated depreciation and amortization		(349,118)
Real estate investments, net		2,231,530
Accounts and other receivables, net		0
Receivables and other assets, net		84,970
Other intangibles, net		$ 44,011

XML

Receivables and Other Assets (Tables)

9 Months Ended

Sep. 30, 2013

Receivables and Other Assets [Abstract]

Schedule of Receivables and Other Assets

Receivables and other assets consisted of the following as of September 30, 2013 and December 31, 2012 (in thousands):

	September 30, 2013		December 31, 2012
Accounts and other receivables, net	$	19,595	$	13,317
Tenant note receivable	3,202		3,287
Deferred financing costs, net	11,395		11,006
Deferred leasing costs, net	12,223		10,554
Lease inducements, net	762		880
Straight-line rent receivables, net	44,861		39,095
Prepaid expenses, deposits, equipment and other	9,302		6,831
Derivative financial instruments - interest rate swaps	3,656		—
Total	$	104,996	$	84,970

Schedule of Receivables and Other Assets Amortization Expense

The following is a summary of amortization of deferred leasing costs, deferred financing costs, and lease inducements for the three and nine months ended September 30, 2013 and 2012 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Amortization expense related to deferred leasing costs	$	686	$	568	$	1,844	$	1,436
Interest expense related to deferred financing costs	805		896		3,030		2,987
Amortization recorded against rental income related to lease inducements	56		54		156		220

XML

Intangibles Assets and Liabilities (Tables)

9 Months Ended

Sep. 30, 2013

Identified Intangibles, Net [Abstract]

Schedule of Identified Intangible Assets and Liabilities, Net

Intangible assets and liabilities consisted of the following as of September 30, 2013 and December 31, 2012 (in thousands, except weighted average remaining amortization period):

	September 30, 2013				December 31, 2012
	Balance			Weighted Average Remaining Amortization Period in Years	Balance			Weighted Average Remaining Amortization Period in Years	Balance Sheet Classification
Assets:
In place leases	$	197,185		8.7	$	174,615		9.7	Lease intangibles
Tenant relationships	189,616			10.6	178,269			11.6	Lease intangibles
Above market leases	25,878			6.3	25,387			6.9	Other intangibles, net
Below market leasehold interests	29,128			63.9	30,587			69.4	Other intangibles, net
	441,807				408,858
Accumulated amortization	(143,160		)		(125,924		)
Total	$	298,647			$	282,934
Liabilities:
Below market leases	$	13,548		13.0	$	12,823		13.7	Intangible liabilities, net
Above market leasehold interests	3,827			33.3	3,827			34.0	Intangible liabilities, net
	17,375				16,650
Accumulated amortization	(6,113		)		(5,341		)
Total	$	11,262			$	11,309

Summary of Intangible Asset and Liabilties Amortization

The following is a summary of the net intangible amortization for the three and nine months ended September 30, 2013 and 2012 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Amortization recorded against rental income related to above or below market leases	$	417	$	470	$	1,298	$	1,185
Rental expense related to above or below market leasehold interests	89		106		278		413
Amortization expense related to in place leases and tenant relationships	9,955		10,705		29,912		32,151

XML

Debt - Net (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Debt Instrument
Total debt, gross	$ 1,125,636,000	$ 1,034,956,000
Net premium	156,000	2,403,000
Total	1,125,792,000	1,037,359,000
Unsecured term loans
Debt Instrument
Total debt, gross	455,000,000	455,000,000
Unsecured senior notes
Debt Instrument
Total debt, gross	300,000,000	0
Fixed rate mortgages
Debt Instrument
Total debt, gross	370,636,000	382,456,000
Secured real estate term loan
Debt Instrument
Total debt, gross	0	125,500,000
Unsecured revolving credit facility
Debt Instrument
Line of credit facility, amount outstanding	$ 0	$ 72,000,000

XML

Per Unit Data (Tables)

9 Months Ended

Sep. 30, 2013

Earnings Per Share [Abstract]

Schedule of Earnings Per Unit, Basic and Diluted

The following is the reconciliation of the numerator and denominator used in basic and diluted earnings (losses) per unit of HTALP (in thousands, except per unit data):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2013		2012			2013		2012
Numerator:
Income (loss) from continuing operations attributable to controlling interest	$	4,616	$	(3,094	)	$	19,858	$	(22,989	)
Discontinued operations	380		143			725		410
Net income (loss) attributable to controlling interest	$	4,996	$	(2,951	)	$	20,583	$	(22,579	)
Denominator:
Weighted average number of units outstanding - basic	235,570		221,413			228,188		227,105
Dilutive units	—		—			—		—
Weighted average number of units outstanding - diluted	235,570		221,413			228,188		227,105
Earnings (losses) per unit attributable to controlling interest - basic:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Earnings (losses) per unit attributable to controlling interest - diluted:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)

XML

Real Estate Notes Receivable (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013 promissory_notes	Dec. 31, 2012
Portfolio One
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of promissory notes secured by office buildings	4
Total real estate notes receivable	$ 20.0	$ 20.0
Interest rate, minimum	10.85%
Interest rate, maximum	10.95%
Interest rate	14.57%
Portfolio Two
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of promissory notes secured by office buildings	2
Total real estate notes receivable	$ 8.5
Interest rate	7.00%

XML

Derivative Financial Instruments - Derivative Instruments Fair Value Table (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Derivatives, Fair Value
Fair value, asset	$ 3,656	$ 0
Derivative financial instruments, liability	3,258	9,370
Interest Rate Swap | Not Designated as Hedging Instrument | Receivables and Other Assets
Derivatives, Fair Value
Fair value, asset	3,656
Interest Rate Swap | Not Designated as Hedging Instrument | Derivative Financial Instruments
Derivatives, Fair Value
Derivative financial instruments, liability	$ 3,258	$ 9,370

XML

Stockholders' Equity and Partners' Capital (Tables)

9 Months Ended

Sep. 30, 2013

Class of Stock

Dividends Declared

The following are the cash dividends declared by HTA on all Class A and B common stock during 2013:

Declaration Date	Record Date	Amount Per Share		Payment Date
January 18, 2013	March 29, 2013	$	0.14375	April 4, 2013
April 26, 2013	June 27, 2013	0.14375		July 3, 2013
August 1, 2013	September 27, 2013	0.14375		October 4, 2013
November 4, 2013	December 27, 2013	0.14375		January 3, 2014

Long Term Incentive Program

Class of Stock

Schedule of Nonvested Share Activity

The following is a summary of the activity in our LTIP units during 2013:

	LTIP Units		Weighted Average Grant Date Fair Value
Balance as of December 31, 2012	2,900,000		$	6.25
Granted	—		—
Vested	(2,380,700	)	5.56
Forfeited	(2,100	)	5.62
Balance as of September 30, 2013	517,200		$	9.42

Restricted Stock

Class of Stock

Schedule of Nonvested Share Activity

The following is a summary of the activity in our restricted common stock during 2013:

	Restricted Common Stock		Weighted Average Grant Date Fair Value
Balance as of December 31, 2012	376,500		$	9.98
Granted	475,500		10.56
Vested	(92,500	)	10.10
Forfeited	(63,500	)	10.00
Balance as of September 30, 2013	696,000		$	10.35

XML

Receivables and Other Assets (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Receivables and Other Assets [Abstract]
Accounts and other receivables, net	$ 19,595		$ 19,595		$ 13,317
Tenant note receivable	3,202		3,202		3,287
Deferred financing costs, net	11,395		11,395		11,006
Deferred leasing costs, net	12,223		12,223		10,554
Lease inducements, net	762		762		880
Straight-line rent receivables, net	44,861		44,861		39,095
Prepaid expenses, deposits, equipment and other	9,302		9,302		6,831
Derivative financial instruments - interest rate swaps	3,656		3,656		0
Total	104,996		104,996		84,970
Tenant note receivable, interest rate			9.00%
Amortization expense related to deferred leasing costs	686	568	1,844	1,436
Interest expense related to deferred financing costs	805	896	3,030	2,987
Amortization recorded against rental income related to lease inducements	$ 56	$ 54	$ 156	$ 220

XML

Business Combinations (Tables)

9 Months Ended

Sep. 30, 2013

Business Combinations [Abstract]

Schedule of Purchase Price Allocation

The aggregate net purchase price of the 2013 acquisitions was allocated in the amounts set forth in the table below. Due to the recent timing of certain acquisitions, we have not yet finalized our purchase price allocation. Since the acquisitions were determined to be individually not significant, but material on a collective basis, the allocations for these acquisitions are set forth below in the aggregate (in thousands):

2013 Acquisitions	Total
Land	$	13,415
Building and improvements	175,039
Below market leasehold interests	1,836
Above market leases	1,987
In place leases	32,205
Tenant relationships	16,541
Below market leases	(1,167		)
Above market debt	(241		)
Net assets acquired	239,615
Other, net	2,299
Aggregate purchase price	$	241,914

The aggregate net purchase price of the 2012 acquisitions was allocated in the amounts set forth in the table below. Since the acquisitions were determined to be individually not significant, but material on a collective basis, the allocations for these acquisitions are set forth below in the aggregate (in thousands):

2012 Acquisitions	Total
Land	$	3,809
Building and improvements	214,772
Below market leasehold interests	3,284
Above market leases	4,199
In place leases	23,388
Tenant relationships	19,863
Below market leases	(1,415		)
Net assets acquired	267,900
Other, net	287
Aggregate purchase price	$	268,187

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income (loss)	$ 20,622	$ (22,551)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, amortization and other	86,654	85,941
Share-based compensation expense	5,129	12,290
Bad debt expense	107	578
Change in fair value of derivative financial instruments	(8,573)	7,815
Changes in operating assets and liabilities:
Receivables and other assets	(13,569)	(4,370)
Accounts payable and accrued liabilities	21,928	6,560
Security deposits, prepaid rent and other liabilities	6,377	(2,460)
Net cash provided by operating activities	118,675	83,803
Cash flows from investing activities:
Acquisition of real estate operating properties and other assets	(223,839)	(230,636)
Capital expenditures	(16,486)	(18,341)
Issuance of real estate notes receivable	(8,520)	0
Restricted cash, escrow deposits and notes receivable	(2,446)	(4,840)
Release of restricted cash	0	580
Real estate deposits paid	0	(3,810)
Real estate deposits used	0	4,810
Net cash used in investing activities	(251,291)	(252,237)
Cash flows from financing activities:
Proceeds from unsecured senior notes	297,558	0
Borrowings on unsecured revolving credit facility	103,000	281,000
Payments on unsecured revolving credit facility	(175,000)	(268,000)
Borrowings on unsecured term loans	0	455,000
Payments on secured real estate term loan and mortgage loans	(155,302)	(106,532)
Deferred financing costs	(3,471)	(6,439)
Derivative financial instrument termination payments	(1,195)	0
Security deposits	967	551
Proceeds from issuance of common stock, net	229,498	0
Repurchase and cancellation of common stock	(287)	(182,397)
Payment of offering costs	0	(2,884)
Dividends	(95,597)	(62,457)
Payment on earnout liability	(92)	(328)
Distributions to noncontrolling interest of limited partners	(1,238)	(231)
Net cash provided by financing activities	198,841	107,283
Net change in cash and cash equivalents	66,225	(61,151)
Cash and cash equivalents - beginning of period	15,956	69,491
Cash and cash equivalents - end of period	82,181	8,340
Healthcare Trust of America Holdings, LP (HTALP)
Cash flows from operating activities:
Net income (loss)	20,622	(22,551)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, amortization and other	86,654	85,941
Share-based compensation expense	5,129	12,290
Bad debt expense	107	578
Change in fair value of derivative financial instruments	(8,573)	7,815
Changes in operating assets and liabilities:
Receivables and other assets	(13,569)	(4,370)
Accounts payable and accrued liabilities	21,928	6,560
Security deposits, prepaid rent and other liabilities	6,377	(2,460)
Net cash provided by operating activities	118,675	83,803
Cash flows from investing activities:
Acquisition of real estate operating properties and other assets	(223,839)	(230,636)
Capital expenditures	(16,486)	(18,341)
Issuance of real estate notes receivable	(8,520)	0
Restricted cash, escrow deposits and notes receivable	(2,446)	(4,840)
Release of restricted cash	0	580
Real estate deposits paid	0	(3,810)
Real estate deposits used	0	4,810
Net cash used in investing activities	(251,291)	(252,237)
Cash flows from financing activities:
Proceeds from unsecured senior notes	297,558	0
Borrowings on unsecured revolving credit facility	103,000	281,000
Payments on unsecured revolving credit facility	(175,000)	(268,000)
Borrowings on unsecured term loans	0	455,000
Payments on secured real estate term loan and mortgage loans	(155,302)	(106,532)
Deferred financing costs	(3,471)	(6,439)
Derivative financial instrument termination payments	(1,195)	0
Security deposits	967	551
Proceeds from issuance of general partner units, net	229,498	0
Repurchase and cancellation of general partner units	(287)	(182,397)
Payment of offering costs	0	(2,884)
Distributions to general partner	(95,597)	(62,457)
Payment on earnout liability	(92)	(328)
Distributions to limited partners and redeemable noncontrolling interests	(1,238)	(231)
Net cash provided by financing activities	198,841	107,283
Net change in cash and cash equivalents	66,225	(61,151)
Cash and cash equivalents - beginning of period	15,956	69,491
Cash and cash equivalents - end of period	$ 82,181	$ 8,340

XML

Organization and Description of Business

9 Months Ended

Sep. 30, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Description of Business

Organization and Description of Business

Healthcare Trust of America, Inc., a Maryland corporation, and Healthcare Trust of America Holdings, LP, a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006. Healthcare Trust of America, Inc. (“HTA”) operates as a real estate investment trust, or REIT, and is the general partner of Healthcare Trust of America Holdings, LP (“HTALP”) which is the operating partnership. As of September 30, 2013, HTA owned an approximate 98.94% partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including long term incentive plan units) in HTALP. As the sole general partner of HTALP, HTA has the full, exclusive and complete responsibility for HTALP’s day-to-day management and control. HTA’s only material asset is its ownership of partnership interests of HTALP. As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP, issuing public equity from time to time and guaranteeing certain debt of HTALP. HTALP holds substantially all of the assets of the Company. HTALP conducts the operations of the business of the Company and is structured as a limited partnership with no publicly traded equity.

HTA is a fully integrated, self-administered and internally managed REIT and conducts substantially all of its operations through HTALP. We are primarily focused on acquiring, owning and operating high-quality medical office buildings that are predominantly located on, or aligned with, campuses of nationally or regionally recognized healthcare systems. HTA is one of the largest public REITs focused on medical office buildings in the United States based on gross leasable area, or GLA, and has strong industry relationships, a stable and diversified tenant mix, and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments and to provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we (i) target mid-sized acquisitions of high-quality medical office buildings in markets with dominant healthcare systems, attractive demographics and that complement our existing portfolio, (ii) actively manage our balance sheet to maintain flexibility with conservative leverage, and (iii) seek internal growth through proactive asset management, leasing and property management oversight. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT.

We invest primarily in high-quality medical office buildings in our target markets, and have acquired high-quality medical office buildings and other facilities that serve the healthcare industry with an aggregate purchase price of $2.8 billion through September 30, 2013. As of September 30, 2013, our portfolio consisted of 260 medical office buildings and 19 other facilities that serve the healthcare industry, as well as real estate notes receivable secured by medical office buildings.

On June 6, 2012, HTA listed its Class A common stock on the New York Stock Exchange, or the NYSE, or the Listing. In accordance with an amendment to HTA’s charter approved by stockholders on December 20, 2010, all of the common stock was converted into Class A, Class B-1, Class B-2 and Class B-3 common stock. The Class B common stock is identical to the Class A common stock except that the Class B common stock is not currently listed on a national securities exchange. The shares of the Class B-1 and Class B-2 common stock converted into shares of our Class A common stock on December 6, 2012 and June 6, 2013, respectively, and are now listed on the NYSE. On November 4, 2013, HTA’s Board of Directors announced that the Class B-3 common stock will convert to Class A common stock after the market closes on November 7, 2013 and be eligible for trading on the NYSE.

Our principal executive offices are located at 16435 N. Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.

XML

Real Estate Notes Receivable

9 Months Ended

Sep. 30, 2013

Real Estate Notes Receivable, Net [Abstract]

Real Estate Notes Receivable

Real Estate Notes Receivable

Real estate notes receivable includes four promissory notes totaling $20.0 million as of September 30, 2013 and December 31, 2012. The promissory notes are secured by medical office buildings, with interest rates ranging from 10.85% to 10.95% per annum. The weighted average effective interest rate based on the purchase price of the notes was 14.57% per annum as of September 30, 2013. The promissory notes matured on November 1, 2013 and we expect to receive payment on the principal balance or extend the maturity date during the quarter ending December 31, 2013. The promissory notes have sufficient collateral coverage based on the value of the medical office buildings. The promissory notes will continue to accrue interest as the same per annum rates and as of September 30, 2013 all interest payments were current.

In addition, we originated two promissory notes in September 2013 totaling $8.5 million. The promissory notes are secured by medical office buildings in South Florida, each with an interest rate of 7.0% per annum. The properties are being actively marketed for sale and the notes will be repaid upon any sale. The promissory notes mature on October 1, 2016.

We monitor the credit quality of our real estate notes receivable on an ongoing basis by tracking possible credit quality indicators. As of September 30, 2013, all of our real estate notes receivable are current and we have not provided for any allowance for losses or recorded any impairments with respect to our notes receivable. We made no purchases or sales of real estate notes receivable during the nine months ended September 30, 2013.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

The summary of significant accounting policies presented below is designed to assist in understanding our condensed consolidated financial statements. Such condensed consolidated financial statements and the accompanying notes are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America, or GAAP, in all material respects, and have been consistently applied in preparing our accompanying condensed consolidated financial statements.

Reclassifications

To better present our real estate related balances, we have chosen to break out the details of real estate investments (net) in our balance sheet as opposed to disclosing the details in a footnote. In addition, we have reclassified certain accounts, as further discussed below, in HTA’s previously issued balance sheet to conform to current period presentation. In place leases and tenant relationship intangibles are now included in real estate investments (net) as lease intangibles. In addition, accounts and other receivables (net) have been combined with receivables and other assets (net). None of the revised reclassifications reflect corrections of any amounts. The following table presents the previously reported balances of and the reclassified balances for the impacted line items of the December 31, 2012 balance sheet (in thousands):

	December 31, 2012
	As Previously Reported		As Reclassified
Real estate investments:
Land	$	—	$	183,651
Building and improvements	—		2,044,113
Lease intangibles	—		352,884
	—		2,580,648
Accumulated depreciation and amortization	—		(349,118		)
Real estate investments, net	1,992,607		2,231,530
Accounts and other receivables, net	13,317		—
Receivables and other assets, net	71,653		84,970
Other intangibles, net	282,934		44,011

Real Estate Depreciation

Depreciation expense of buildings and improvements for the three months ended September 30, 2013 and 2012, was $18.9 million and $17.8 million, respectively. Depreciation expense of buildings and improvements for the nine months ended September 30, 2013 and 2012, was $55.5 million and $53.0 million, respectively.

Listing Expenses

Listing expenses primarily include fees associated with the Listing and share-based compensation expense associated with the long term incentive program, or LTIP, awards that we granted in connection with the Listing.

Noncontrolling Interests

HTA’s net income attributable to noncontrolling interests in its accompanying condensed consolidated statements of operations relate to both noncontrolling interest reflected within equity and redeemable noncontrolling interest of limited partners reflected outside of equity in our accompanying condensed consolidated balance sheets. Limited partner units in HTALP are accounted for as partners’ capital in HTALP’s condensed consolidated balance sheets and as noncontrolling interest reflected within equity or redeemable noncontrolling interest of limited partners reflected outside of equity in HTA’s condensed consolidated balance sheets.

Interim Unaudited Financial Data

Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the Securities and Exchange Commission, or the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim period. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in the 2012 Annual Report on Form 10-K for HTA and the Registration Statement on Form S-4 for HTALP, as amended, that was declared effective by the SEC on October 22, 2013 (File No. 333-190916).

Recently Issued or Adopted Accounting Pronouncements

In January 2013, the Financial Accounting Standards Board, or the FASB, issued Accounting Standards Update, or ASU, 2013-01, Balance Sheet (Topic 210) - Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, or ASU 2013-01, which clarifies the scope of ASU 2011-11, Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities. ASU 2013-01 requires entities to disclose both gross and net information about derivatives, including bifurcated embedded derivatives, repurchase agreements and reverse purchase agreements and securities borrowing and securities lending transactions that are subject to an agreement similar to a master netting arrangement. Entities are required to apply these disclosures for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. An entity must provide the disclosures required by those amendments retrospectively for all comparative periods presented. We adopted ASU 2011-11 and ASU 2013-01 in the first quarter of fiscal 2013 and have reflected the adoption in our disclosures to our interim condensed consolidated financial statements.

XML

Intangibles Assets and Liabilities (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Finite-Lived Intangibles
Finite-lived intangible assets, gross	$ 441,807	$ 408,858
Accumulated amortization	(143,160)	(125,924)
Assets Total	298,647	282,934
Finite-lived intangible liabilities, gross	17,375	16,650
Accumulated amortization	(6,113)	(5,341)
Liabilities Total	11,262	11,309
Below Market Leases
Finite-Lived Intangibles
Finite-lived intangible liabilities, gross	13,548	12,823
Liabilities, Weighted average remaining amortization period in years	13 years	13 years 8 months 12 days
Above Market Leasehold Interests
Finite-Lived Intangibles
Finite-lived intangible liabilities, gross	3,827	3,827
Liabilities, Weighted average remaining amortization period in years	33 years 3 months 18 days	34 years
In Place Leases
Finite-Lived Intangibles
Finite-lived intangible assets, gross	197,185	174,615
Assets, Weighted average remaining amortization period in years	8 years 8 months 12 days	9 years 8 months 12 days
Tenant Relationships
Finite-Lived Intangibles
Finite-lived intangible assets, gross	189,616	178,269
Assets, Weighted average remaining amortization period in years	10 years 7 months 6 days	11 years 7 months 6 days
Above Market Leases
Finite-Lived Intangibles
Finite-lived intangible assets, gross	25,878	25,387
Assets, Weighted average remaining amortization period in years	6 years 3 months 18 days	6 years 10 months 24 days
Below Market Leasehold Interests
Finite-Lived Intangibles
Finite-lived intangible assets, gross	$ 29,128	$ 30,587
Assets, Weighted average remaining amortization period in years	63 years 10 months 24 days	69 years 4 months 24 days

XML

Assets Held for Sale and Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2013

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures

The following table represents the major classes of assets and liabilities, and the balance sheet classification as of September 30, 2013 (in thousands):

	September 30, 2013
Land	$	5,109
Building and improvements, net	15,181
Lease intangibles, net	848
Property held for sale, net	$	21,138
Receivables and other assets, net	$	1,009
Non-real estate assets of property held for sale, net	$	1,009
Security deposits, prepaid rent and other liabilities	$	181
Security deposits, prepaid rent and other liabilities	$	181

The table below reflects the results of operations of the property classified as held for sale, which are included in discontinued operations for the three and nine months ended September 30, 2013 and 2012 (in thousands):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2013		2012			2013			2012
Revenues:
Rental income	$	443	$	566		$	1,257		$	1,697
Expenses:
Rental	63		65			200			216
Depreciation and amortization	—		230			171			688
Total expenses	63		295			371			904
Income before other income (expense)	380		271			886			793
Other income (expense):
Interest expense related to debt	—		(128		)	(161		)	(383		)
Income from discontinued operations	$	380	$	143		$	725		$	410

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2013

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The table below presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2013, aggregated by the level in the fair value hierarchy (in thousands):

	Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1 )		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets:
Derivative financial instruments	$	—	$	3,656	$	—	$	3,656
Total assets at fair value	$	—	$	3,656	$	—	$	3,656
Liabilities:
Derivative financial instruments	$	—	$	3,258	$	—	$	3,258
Total liabilities at fair value	$	—	$	3,258	$	—	$	3,258

The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2012, aggregated by the level in the fair value hierarchy (in thousands):

	Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1 )		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets:
Derivative financial instruments	$	—	$	—	$	—	$	—
Total assets at fair value	$	—	$	—	$	—	$	—
Liabilities:
Derivative financial instruments	$	—	$	9,370	$	—	$	9,370
Total liabilities at fair value	$	—	$	9,370	$	—	$	9,370

Schedule of Fair Value of Financial Instruments

The following table sets forth the carrying value and fair value of our real estate notes receivable, tenant note receivable and debt (net) (in thousands):

		September 30, 2013				December 31, 2012
	Fair Value Level	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Real estate notes receivable	2	$	28,520	$	28,520	$	20,000	$	20,000
Tenant note receivable	2	3,202		3,098		3,287		3,337
Debt, net	2	1,125,792		1,149,460		1,037,359		1,087,168

XML

Summary of Significant Accounting Policies (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Accounting Policies [Abstract]
Depreciation expense	$ 18.9	$ 17.8	$ 55.5	$ 53.0

XML

Fair Value of Financial Instruments - Assets and Liabilities at Fair Value (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivative financial instruments, asset	$ 3,656	$ 0
Derivative financial instruments, liability	3,258	9,370
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1 )
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivative financial instruments, asset	0	0
Total assets at fair value	0	0
Derivative financial instruments, liability	0	0
Total liabilities at fair value	0	0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivative financial instruments, asset	3,656	0
Total assets at fair value	3,656	0
Derivative financial instruments, liability	3,258	9,370
Total liabilities at fair value	3,258	9,370
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivative financial instruments, asset	0	0
Total assets at fair value	0	0
Derivative financial instruments, liability	0	0
Total liabilities at fair value	0	0
Fair Value, Measurements, Recurring | Total
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivative financial instruments, asset	3,656	0
Total assets at fair value	3,656	0
Derivative financial instruments, liability	3,258	9,370
Total liabilities at fair value	$ 3,258	$ 9,370

XML

Derivative Financial Instruments - Derivative Offsetting (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative financial instruments, asset	$ 3,656	$ 0
Derivative assets, amounts subject to enforceable master netting arrangements	(2,490)	0
Derivative assets, net amounts	1,166	0
Derivative liabilities	3,258	9,370
Derivative liabilities, amounts subject to enforceable master netting arrangements	(2,490)	0
Derivative liabilities, net amounts	$ 768	$ 9,370

XML

Debt - Textuals (Details) (USD $)			9 Months Ended		0 Months Ended				0 Months Ended		9 Months Ended		0 Months Ended			0 Months Ended	9 Months Ended	0 Months Ended		9 Months Ended		0 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013 Fixed rate mortgages	Dec. 31, 2012 Fixed rate mortgages	Mar. 28, 2013 Secured real estate term loan	Sep. 30, 2013 Secured real estate term loan	Dec. 31, 2012 Secured real estate term loan	Mar. 28, 2013 Interest Rate Swap	Mar. 29, 2012 JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc.	Mar. 07, 2013 Unsecured revolving credit facility JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc.	Sep. 30, 2013 Unsecured revolving credit facility JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc.	Mar. 29, 2012 Unsecured revolving credit facility JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc.	Mar. 07, 2013 Unsecured revolving credit facility JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc. Minimum	Mar. 07, 2013 Unsecured revolving credit facility JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc. Maximum	Sep. 30, 2013 Unsecured term loans JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc., With Interest Rate Swap	Mar. 29, 2012 Unsecured term loans JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc.	Sep. 30, 2013 Unsecured term loans JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc.	Mar. 29, 2012 Unsecured term loans JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc. Minimum	Mar. 29, 2012 Unsecured term loans JPMorgan Securities, LLC, Wells Fargo Securities, LLC and Deutsche Bank Securities Inc. Maximum	Sep. 30, 2013 Unsecured term loans Wells Fargo	Jul. 20, 2012 Unsecured term loans Wells Fargo	Jul. 20, 2012 Unsecured term loans Wells Fargo Minimum	Jul. 20, 2012 Unsecured term loans Wells Fargo Maximum	Sep. 30, 2013 Unsecured term loans Wells Fargo, With Interest Rate Swap	Mar. 28, 2013 Unsecured senior notes
Debt Instrument
Line of credit facility, borrowing capacity										$ 650,000,000.0		$ 575,000,000
Long-term debt	1,125,636,000	1,034,956,000	370,636,000	382,456,000		0	125,500,000									300,000,000					155,000,000				300,000,000
Line of credit facility, maximum borrowing capacity, increase in capacity										75,000,000.0
Unsecured credit agreement, extension option period									1 year
Description of variable rate basis										LIBOR						LIBOR
Basis spread on variable rate											1.55%		1.10%	1.75%			1.85%	1.30%	2.25%	2.00%		1.55%	2.40%
Line of credit facility, unused capacity, commitment fee percentage											0.35%		0.20%	0.50%
Debt instrument, interest rate															2.95%									3.29%
Debt instrument, interest rate																									3.70%
Debt instrument, percentage of principal amount received																									99.186%
Effective percentage rate range, minimum			4.55%
Effective percentage rate range, maximum			12.75%
Weighted average interest rate			5.86%
Repayments of debt					125,500,000
Notional amount terminated								$ 75,000,000

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Equity:
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A
Equity:
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized	900,000,000	700,000,000
Common stock, shares issued	178,475,080	100,086,387
Common stock, shares outstanding	178,475,080	100,086,387
Class B
Equity:
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	300,000,000
Common stock, shares issued	57,268,109	114,566,254
Common stock, shares outstanding	57,268,109	114,566,254
Healthcare Trust of America Holdings, LP (HTALP)
Partners’ Capital:
Limited partner's capital, units issued	3,053,618	3,055,718
Limited partner's capital, units outstanding	3,053,618	3,055,718
General partner's capital, units issued	235,743,189	214,652,641
General partner's capital, units outstanding	235,743,189	214,652,641

XML

Assets Held for Sale and Discontinued Operations

9 Months Ended

Sep. 30, 2013

Discontinued Operations and Disposal Groups [Abstract]

Assets Held for Sale and Discontinued Operations

Assets Held for Sale and Discontinued Operations

During 2013 we classified one of our properties as held for sale as we committed to an approved plan to seek to dispose of the property. The sale of the property is expected to occur within one year. As of December 31, 2012, there were no properties held for sale. The following table represents the major classes of assets and liabilities, and the balance sheet classification as of September 30, 2013 (in thousands):

	September 30, 2013
Land	$	5,109
Building and improvements, net	15,181
Lease intangibles, net	848
Property held for sale, net	$	21,138
Receivables and other assets, net	$	1,009
Non-real estate assets of property held for sale, net	$	1,009
Security deposits, prepaid rent and other liabilities	$	181
Security deposits, prepaid rent and other liabilities	$	181

The table below reflects the results of operations of the property classified as held for sale, which are included in discontinued operations for the three and nine months ended September 30, 2013 and 2012 (in thousands):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2013		2012			2013			2012
Revenues:
Rental income	$	443	$	566		$	1,257		$	1,697
Expenses:
Rental	63		65			200			216
Depreciation and amortization	—		230			171			688
Total expenses	63		295			371			904
Income before other income (expense)	380		271			886			793
Other income (expense):
Interest expense related to debt	—		(128		)	(161		)	(383		)
Income from discontinued operations	$	380	$	143		$	725		$	410

XML

Condensed Consolidated Statements of Equity (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	Total USD ($)	Common Stock USD ($)	Additional Paid-In Capital USD ($)	Cumulative Dividends in Excess of Earnings USD ($)	Total Stockholders’ Equity USD ($)	Noncontrolling Interest USD ($)	Class A	Class A Common Stock	Class B	Class B Common Stock
Beginning balance at Dec. 31, 2011	$ 1,567,340	$ 2,284	$ 2,032,305	$ (467,249)	$ 1,567,340	$ 0
Beginning balance, shares at Dec. 31, 2011		228,491,000						0		0
Increase (Decrease) in Stockholders' Equity
Share-based award transactions, net (in shares)		626,000						41,000		12,000
Share-based award transactions, net	12,290	7	6,358	0	6,365	5,925
Issuance of common stock under the DRIP (in shares)		3,362,000						0		0
Issuance of common stock under the DRIP	31,915	33	31,882	0	31,915	0
Repurchase and cancellation of common stock (in shares)		(3,070,000)						(14,936,000)		(144,000)
Repurchase and cancellation of common stock	(185,278)	(181)	(185,097)	0	(185,278)	0
Conversion (in shares)		(229,409,000)						57,429,000		171,980,000
Dividends	(111,238)	0	0	(111,165)	(111,165)	(73)
Net income (loss)	(22,588)	0	0	(22,588)	(22,588)	0
Ending balance at Sep. 30, 2012	1,292,441	2,143	1,885,448	(601,002)	1,286,589	5,852
Ending balance, shares at Sep. 30, 2012		0						42,534,000		171,848,000
Beginning balance at Dec. 31, 2012	1,264,595	2,147	1,885,836	(633,717)	1,254,266	10,329
Beginning balance, shares at Dec. 31, 2012		0					100,086,387	100,086,000	114,566,254	114,566,000
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)		0						20,707,000		0
Issuance of common stock	228,306	207	228,099	0	228,306	0
Share-based award transactions, net (in shares)		0						427,000		(15,000)
Share-based award transactions, net	5,129	4	1,948	0	1,952	3,177
Issuance of common stock under the DRIP	0
Repurchase and cancellation of common stock (in shares)		0						(28,000)		0
Repurchase and cancellation of common stock	(287)	0	(287)	0	(287)	0
Conversion (in shares)								57,283,000		(57,283,000)
Dividends	(99,584)	0	0	(98,630)	(98,630)	(954)
Net income (loss)	20,552	0	0	20,199	20,199	353
Ending balance at Sep. 30, 2013	$ 1,418,711	$ 2,358	$ 2,115,596	$ (712,148)	$ 1,405,806	$ 12,905
Ending balance, shares at Sep. 30, 2013		0					178,475,080	178,475,000	57,268,109	57,268,000

XML

Per Unit Data (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Numerator:
Income (loss) from continuing operations attributable to controlling interest	$ 4,443	$ (3,095)	$ 19,474	$ (22,998)
Discontinued operations	380	143	725	410
Net income (loss) attributable to controlling interest	4,823	(2,952)	20,199	(22,588)
Denominator:
Weighted average number of shares outstanding — basic (in shares/units)	232,514	218,264	225,132	225,501
Dilutive shares (in shares/units)	2,509	0	1,639	0
Weighted average number of shares outstanding — diluted (in shares/units)	235,023	218,264	226,771	225,501
Earnings (losses) per share/unit attributable to controlling interest - basic:
Continuing operations (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Discontinued operations (usd per share/unit)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net income (loss) (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Earnings (losses) per share/unit attributable to controlling interest - diluted:
Continuing operations (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Discontinued operations (usd per share/unit)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net income (loss) (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Healthcare Trust of America Holdings, LP (HTALP)
Numerator:
Income (loss) from continuing operations attributable to controlling interest	4,616	(3,094)	19,858	(22,989)
Discontinued operations	380	143	725	410
Net income (loss) attributable to controlling interest	$ 4,996	$ (2,951)	$ 20,583	$ (22,579)
Denominator:
Weighted average number of shares outstanding — basic (in shares/units)	235,570	221,413	228,188	227,105
Dilutive shares (in shares/units)	0	0	0	0
Weighted average number of shares outstanding — diluted (in shares/units)	235,570	221,413	228,188	227,105
Earnings (losses) per share/unit attributable to controlling interest - basic:
Continuing operations (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Discontinued operations (usd per share/unit)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net income (loss) (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Earnings (losses) per share/unit attributable to controlling interest - diluted:
Continuing operations (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)
Discontinued operations (usd per share/unit)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net income (loss) (usd per share/unit)	$ 0.02	$ (0.01)	$ 0.09	$ (0.10)

XML

Condensed Consolidated Balance Sheets (Unaudited) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Real estate investments:
Land	$ 195,115	$ 183,651
Building and improvements	2,215,513	2,044,113
Lease intangibles	386,801	352,884
Property held for sale, net	21,138	0
Real estate investments, gross	2,818,567	2,580,648
Accumulated depreciation and amortization	(415,615)	(349,118)
Real estate investments, net	2,402,952	2,231,530
Real estate notes receivable	28,520	20,000
Cash and cash equivalents	82,181	15,956
Restricted cash and escrow deposits	20,068	17,623
Receivables and other assets, net	104,996	84,970
Other intangibles, net	41,794	44,011
Non-real estate assets of property held for sale, net	1,009	0
Total assets	2,681,520	2,414,090
Liabilities:
Debt, net	1,125,792	1,037,359
Accounts payable and accrued liabilities	86,795	63,443
Derivative financial instruments - interest rate swaps	3,258	9,370
Security deposits, prepaid rent and other liabilities	32,327	24,450
Intangible liabilities, net	11,262	11,309
Total liabilities	1,259,434	1,145,931
Commitments and contingencies
Redeemable noncontrolling interest of limited partners	3,375	3,564
Equity/Partners' Capital:
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding	0	0
Additional paid-in capital	2,115,596	1,885,836
Cumulative dividends in excess of earnings	(712,148)	(633,717)
Total stockholders’ equity	1,405,806	1,254,266
Noncontrolling interest	12,905	10,329
Total equity	1,418,711	1,264,595
Total liabilities and equity/partners' capital	2,681,520	2,414,090
Class A
Equity/Partners' Capital:
Common stock, $0.01 par value	1,785	1,001
Class B
Equity/Partners' Capital:
Common stock, $0.01 par value	573	1,146
Healthcare Trust of America Holdings, LP (HTALP)
Real estate investments:
Land	195,115	183,651
Building and improvements	2,215,513	2,044,113
Lease intangibles	386,801	352,884
Property held for sale, net	21,138	0
Real estate investments, gross	2,818,567	2,580,648
Accumulated depreciation and amortization	(415,615)	(349,118)
Real estate investments, net	2,402,952	2,231,530
Real estate notes receivable	28,520	20,000
Cash and cash equivalents	82,181	15,956
Restricted cash and escrow deposits	20,068	17,623
Receivables and other assets, net	104,996	84,970
Other intangibles, net	41,794	44,011
Non-real estate assets of property held for sale, net	1,009	0
Total assets	2,681,520	2,414,090
Liabilities:
Debt, net	1,125,792	1,037,359
Accounts payable and accrued liabilities	86,795	63,443
Derivative financial instruments - interest rate swaps	3,258	9,370
Security deposits, prepaid rent and other liabilities	32,327	24,450
Intangible liabilities, net	11,262	11,309
Total liabilities	1,259,434	1,145,931
Commitments and contingencies
Redeemable noncontrolling interest of limited partners	1,807	1,960
Equity/Partners' Capital:
Limited partners’ capital, 3,053,618 and 3,055,718 units issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	14,203	11,663
General partners’ capital, 235,743,189 and 214,652,641 units issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	1,406,076	1,254,536
Total partners’ capital	1,420,279	1,266,199
Total liabilities and equity/partners' capital	$ 2,681,520	$ 2,414,090

XML

Derivative Financial Instruments - Recognized Gain (Loss) (Details) (Not Designated as Hedging Instrument, Interest Expense, USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Interest Rate Swap
Derivative Instruments, Gain (Loss)
Interest expense related to derivative financial instruments and net change in fair value of derivative financial instruments	$ (1,955)	$ (2,520)	$ 8,573	$ (7,726)
Interest Rate Cap
Derivative Instruments, Gain (Loss)
Interest expense related to derivative financial instruments and net change in fair value of derivative financial instruments	$ 0	$ 0	$ 0	$ (89)

XML

Debt (Tables)

9 Months Ended

Sep. 30, 2013

Debt Disclosure [Abstract]

Schedule of Debt

Debt consisted of the following as of September 30, 2013 and December 31, 2012 (in thousands):

	September 30, 2013		December 31, 2012
Unsecured revolving credit facility	$	—	$	72,000
Unsecured term loans	455,000		455,000
Unsecured senior notes	300,000		—
Fixed rate mortgages	370,636		382,456
Secured real estate term loan	—		125,500
	1,125,636		1,034,956
Net premium	156		2,403
Total	$	1,125,792	$	1,037,359

Schedule of maturities of long-term debt

As of September 30, 2013, the principal payments due on our debt for the three months ending December 31, 2013, for each of the next four years ending December 31 and thereafter, is as follows (in thousands):

Year	Amount
2013	$	1,722
2014	6,872
2015	73,128
2016	421,578
2017	99,963
Thereafter	522,373
Total	$	1,125,636

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Reclassifications

Reclassifications

To better present our real estate related balances, we have chosen to break out the details of real estate investments (net) in our balance sheet as opposed to disclosing the details in a footnote. In addition, we have reclassified certain accounts, as further discussed below, in HTA’s previously issued balance sheet to conform to current period presentation. In place leases and tenant relationship intangibles are now included in real estate investments (net) as lease intangibles. In addition, accounts and other receivables (net) have been combined with receivables and other assets (net). None of the revised reclassifications reflect corrections of any amounts.

Listing Expenses

Listing Expenses

Listing expenses primarily include fees associated with the Listing and share-based compensation expense associated with the long term incentive program, or LTIP, awards that we granted in connection with the Listing.

Noncontrolling Interests

Noncontrolling Interests

HTA’s net income attributable to noncontrolling interests in its accompanying condensed consolidated statements of operations relate to both noncontrolling interest reflected within equity and redeemable noncontrolling interest of limited partners reflected outside of equity in our accompanying condensed consolidated balance sheets. Limited partner units in HTALP are accounted for as partners’ capital in HTALP’s condensed consolidated balance sheets and as noncontrolling interest reflected within equity or redeemable noncontrolling interest of limited partners reflected outside of equity in HTA’s condensed consolidated balance sheets.

Recently Issued or Adopted Accounting Pronouncements

Recently Issued or Adopted Accounting Pronouncements

In January 2013, the Financial Accounting Standards Board, or the FASB, issued Accounting Standards Update, or ASU, 2013-01, Balance Sheet (Topic 210) - Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, or ASU 2013-01, which clarifies the scope of ASU 2011-11, Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities. ASU 2013-01 requires entities to disclose both gross and net information about derivatives, including bifurcated embedded derivatives, repurchase agreements and reverse purchase agreements and securities borrowing and securities lending transactions that are subject to an agreement similar to a master netting arrangement. Entities are required to apply these disclosures for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. An entity must provide the disclosures required by those amendments retrospectively for all comparative periods presented. We adopted ASU 2011-11 and ASU 2013-01 in the first quarter of fiscal 2013 and have reflected the adoption in our disclosures to our interim condensed consolidated financial statements.

XML

Assets Held for Sale and Discontinued Operations (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013 property	Sep. 30, 2012	Sep. 30, 2013 property	Sep. 30, 2012	Dec. 31, 2012
Discontinued Operations and Disposal Groups [Abstract]
Number of properties held-for-sale	1		1
Assets Held-for-sale, period of sale			1 year
Land	$ 5,109		$ 5,109
Building and improvements, net	15,181		15,181
Lease intangibles, net	848		848
Property held for sale, net	21,138		21,138		0
Receivables and other assets, net	1,009		1,009
Security deposits, prepaid rent and other liabilities	181		181
Revenues:
Rental income	443	566	1,257	1,697
Expenses:
Rental	63	65	200	216
Depreciation and amortization	0	230	171	688
Total expenses	63	295	371	904
Income before other income (expense)	380	271	886	793
Other income (expense):
Interest expense related to debt	0	(128)	(161)	(383)
Income from discontinued operations	$ 380	$ 143	$ 725	$ 410

XML

Stockholders' Equity and Partners' Capital - Dividends (Details) (USD $)	0 Months Ended			3 Months Ended		9 Months Ended		0 Months Ended
	Aug. 01, 2013	Apr. 26, 2013	Jan. 18, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Nov. 04, 2013 Subsequent Event
Dividends Payable [Line Items]
Dividends declared per common share (usd per share/unit)	$ 0.14375	$ 0.14375	$ 0.14375	$ 0.14	$ 0.14	$ 0.43	$ 0.49	$ 0.14375

XML

Business Combinations (Details) (USD $)	9 Months Ended	0 Months Ended							9 Months Ended	1 Months Ended
	Sep. 30, 2013 2013 Acquisitions Acquisitions	Aug. 30, 2013 Dallas, Texas	Mar. 11, 2013 Dallas, Texas	Mar. 22, 2013 Bryan - College Station, Texas	Jun. 18, 2013 Atlanta, Georgia	Jul. 12, 2013 Monroeville, Pennsylvania	Jul. 29, 2013 Denver, Colorado	Sep. 20, 2013 South Florida	Sep. 30, 2012 2012 Acquisitions	Nov. 05, 2013 Subsequent Event Austin, Texas agreement
Business Acquisition
Number of businesses acquired	7
Acquisition-related expenses	$ 1,400,000
Business Acquisition, Purchase Price Allocation, Real Estate [Abstract]
Land	13,415,000								3,809,000
Building and improvements	175,039,000								214,772,000
Below market leasehold interests	1,836,000								3,284,000
Above market leases	1,987,000								4,199,000
In place leases	32,205,000								23,388,000
Tenant relationships	16,541,000								19,863,000
Below market leases	(1,167,000)								(1,415,000)
Above market debt	(241,000)
Net assets acquired	239,615,000								267,900,000
Other, net	2,299,000								287,000
Aggregate purchase price	241,914,000	27,700,000	48,700,000	39,800,000	5,600,000	15,100,000	42,000,000	62,900,000	268,187,000
Weighted average lives of acquired intangible assets	7 years 4 months 24 days								14 years 9 months 18 days
Weighted average lives of acquired intangible liabilities	5 years 8 months 12 days								7 years 6 months
Percentage of voting interests acquired		100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Acquisition, assumed mortgage loans								18,000,000
Number of definitive purchase agreements										2
Value of acquisitions under definitive purchase agreement										$ 30,000,000

XML

Supplemental Cash Flow Information (Tables)

9 Months Ended

Sep. 30, 2013

Supplemental Cash Flow Elements [Abstract]

Schedule of Cash Flow, Supplemental Disclosures

The following is the supplemental cash flow information for the nine months ended September 30, 2013 and 2012 (in thousands):

	Nine Months Ended September 30,
	2013		2012
Interest paid	$	27,743	$	30,681
Income taxes paid	904		840
Supplemental Disclosure of Noncash Activities:
Investing Activities:
Accrued capital expenditures	$	2,227	$	1,508
Note receivable included in the consideration for the acquisition of a building	—		37,264
The following represents the significant increase (decrease) in certain assets and liabilities in connection with our acquisition of operating properties:
Debt	$	17,982	$	—
Financing Activities:
Issuances under the DRIP	$	—	$	31,915
Dividend distributions declared, but not paid, including under the DRIP	34,238		30,959
Offering costs transferred to equity/partners’ capital	1,192		—

XML

Organization and Description of Business (Details) (USD $) In Billions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Significant Acquisitions and Disposals
General partnership interest percentage	98.94%
Purchased property inception to current date	$ 2.8
Medical Office Buildings
Significant Acquisitions and Disposals
Number of real estate properties	260
Healthcare Industry Facilities
Significant Acquisitions and Disposals
Number of real estate properties	19

XML

Receivables and Other Assets

9 Months Ended

Sep. 30, 2013

Receivables and Other Assets [Abstract]

Receivables and Other Assets

Receivables and Other Assets

Receivables and other assets consisted of the following as of September 30, 2013 and December 31, 2012 (in thousands):

	September 30, 2013		December 31, 2012
Accounts and other receivables, net	$	19,595	$	13,317
Tenant note receivable	3,202		3,287
Deferred financing costs, net	11,395		11,006
Deferred leasing costs, net	12,223		10,554
Lease inducements, net	762		880
Straight-line rent receivables, net	44,861		39,095
Prepaid expenses, deposits, equipment and other	9,302		6,831
Derivative financial instruments - interest rate swaps	3,656		—
Total	$	104,996	$	84,970

The tenant note receivable is for a loan to a tenant for building improvements. The interest rate thereon is 9.0% per annum and requires monthly principal and interest payments from the tenant through July 2027. As of September 30, 2013, this tenant note receivable is current and we have not provided any allowance for losses, and we have had no impairment with respect to this note receivable.

The following is a summary of amortization of deferred leasing costs, deferred financing costs, and lease inducements for the three and nine months ended September 30, 2013 and 2012 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Amortization expense related to deferred leasing costs	$	686	$	568	$	1,844	$	1,436
Interest expense related to deferred financing costs	805		896		3,030		2,987
Amortization recorded against rental income related to lease inducements	56		54		156		220

XML

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2013

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

The following table lists the derivative financial instrument assets and (liabilities) held by us as of September 30, 2013 (in thousands):

Notional Amount		Index	Rate		Fair Value			Instrument	Maturity
$	200,000	LIBOR	1.23	%	$	(2,490	)	Swap	3/29/2017
100,000		LIBOR	0.86		(768		)	Swap	6/15/2016
50,000		LIBOR	1.39		882			Swap	7/17/2019
105,000		LIBOR	1.24		2,774			Swap	7/17/2019

The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2012 (in thousands):

Notional Amount			Index	Rate		Fair Value			Instrument	Maturity
$	17,304	(a)	LIBOR	3.79	%	$	(459	)	Swap	9/28/2013
75,000		(a)	LIBOR	1.07		(659		)	Swap	12/31/2013
200,000			LIBOR	1.23		(5,180		)	Swap	3/29/2017
100,000			LIBOR	0.86		(1,310		)	Swap	6/15/2016
50,000			LIBOR	1.39		(909		)	Swap	7/17/2019
105,000			LIBOR	1.24		(853		)	Swap	7/17/2019

(a) We terminated the interest rate swaps in March 2013.

Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location

As of September 30, 2013 and December 31, 2012, the gross fair value of our derivative financial instruments was as follows (in thousands):

	Asset Derivatives					Liability Derivatives
	September 30, 2013			December 31, 2012		September 30, 2013			December 31, 2012
Derivatives Not Designated as Hedging Instruments:	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Interest rate swaps	Receivables and other assets	$	3,656	n/a	n/a	Derivative financial instruments	$	3,258	Derivative financial instruments	$	9,370

There were no derivatives offset in our balance sheet as of September 30, 2013 and December 31, 2012. As of September 30, 2013 and December 31, 2012, we had derivatives subject to enforceable master netting arrangements which allow for net cash settlement with the respective counterparties (in thousands):

	September 30, 2013							December 31, 2012
	Gross Amounts		Amounts Subject to Enforceable Master Netting Arrangements			Net Amounts		Gross Amounts		Amounts Subject to Enforceable Master Netting Arrangements		Net Amounts
Asset derivatives	$	3,656	$	(2,490	)	$	1,166	$	—	$	—	$	—
Liability derivatives	3,258		(2,490		)	768		9,370		—		9,370

For the three and nine months ended September 30, 2013 and 2012, the derivative financial instruments had the following effect on our condensed consolidated statements of operations (in thousands):

Derivatives Not Designated as Hedging Instruments:	Location of Gain (Loss) Recognized	Three Months Ended September 30,						Nine Months Ended September 30,
		2013			2012			2013		2012
Interest rate swaps	Interest related to derivative financial instruments and net change in fair value of derivative financial instruments	$	(1,955	)	$	(2,520	)	$	8,573	$	(7,726	)
Interest rate cap	Interest related to derivative financial instruments and net change in fair value of derivative financial instruments	—			—			—		(89		)

XML

Intangibles Assets and Liabilities - Summary of Intangible Amortization (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Amortization recorded against rental income related to above or below market leases
Acquired Finite-Lived Intangibles
Amortization of intangible assets and liabilties	$ 417	$ 470	$ 1,298	$ 1,185
Rental expense related to above or below market leasehold interests
Acquired Finite-Lived Intangibles
Amortization of intangible assets and liabilties	89	106	278	413
Amortization expense related to in place leases and tenant relationships
Acquired Finite-Lived Intangibles
Amortization of intangible assets and liabilties	$ 9,955	$ 10,705	$ 29,912	$ 32,151

XML

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2013

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments

The following table lists the derivative financial instrument assets and (liabilities) held by us as of September 30, 2013 (in thousands):

Notional Amount		Index	Rate		Fair Value			Instrument	Maturity
$	200,000	LIBOR	1.23	%	$	(2,490	)	Swap	3/29/2017
100,000		LIBOR	0.86		(768		)	Swap	6/15/2016
50,000		LIBOR	1.39		882			Swap	7/17/2019
105,000		LIBOR	1.24		2,774			Swap	7/17/2019

The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2012 (in thousands):

Notional Amount			Index	Rate		Fair Value			Instrument	Maturity
$	17,304	(a)	LIBOR	3.79	%	$	(459	)	Swap	9/28/2013
75,000		(a)	LIBOR	1.07		(659		)	Swap	12/31/2013
200,000			LIBOR	1.23		(5,180		)	Swap	3/29/2017
100,000			LIBOR	0.86		(1,310		)	Swap	6/15/2016
50,000			LIBOR	1.39		(909		)	Swap	7/17/2019
105,000			LIBOR	1.24		(853		)	Swap	7/17/2019

(a) We terminated the interest rate swaps in March 2013.

As of September 30, 2013 and December 31, 2012, the gross fair value of our derivative financial instruments was as follows (in thousands):

	Asset Derivatives					Liability Derivatives
	September 30, 2013			December 31, 2012		September 30, 2013			December 31, 2012
Derivatives Not Designated as Hedging Instruments:	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Interest rate swaps	Receivables and other assets	$	3,656	n/a	n/a	Derivative financial instruments	$	3,258	Derivative financial instruments	$	9,370

There were no derivatives offset in our balance sheet as of September 30, 2013 and December 31, 2012. As of September 30, 2013 and December 31, 2012, we had derivatives subject to enforceable master netting arrangements which allow for net cash settlement with the respective counterparties (in thousands):

	September 30, 2013							December 31, 2012
	Gross Amounts		Amounts Subject to Enforceable Master Netting Arrangements			Net Amounts		Gross Amounts		Amounts Subject to Enforceable Master Netting Arrangements		Net Amounts
Asset derivatives	$	3,656	$	(2,490	)	$	1,166	$	—	$	—	$	—
Liability derivatives	3,258		(2,490		)	768		9,370		—		9,370

For the three and nine months ended September 30, 2013 and 2012, the derivative financial instruments had the following effect on our condensed consolidated statements of operations (in thousands):

Derivatives Not Designated as Hedging Instruments:	Location of Gain (Loss) Recognized	Three Months Ended September 30,						Nine Months Ended September 30,
		2013			2012			2013		2012
Interest rate swaps	Interest related to derivative financial instruments and net change in fair value of derivative financial instruments	$	(1,955	)	$	(2,520	)	$	8,573	$	(7,726	)
Interest rate cap	Interest related to derivative financial instruments and net change in fair value of derivative financial instruments	—			—			—		(89		)

We have agreements with each of our interest rate swap derivative counterparties that contain a provision whereby if we default on certain of our unsecured indebtedness, then our counterparties could declare us in default on our interest rate swap derivative obligations resulting in an acceleration of the indebtedness. In addition, we are exposed to credit risk in the event of non-performance by our derivative counterparties. We believe we mitigate the credit risk by entering into agreements with credit-worthy counterparties. We record counterparty credit risk valuation adjustments on interest rate swap derivative assets in order to properly reflect the credit quality of the counterparty. In addition, our fair value of interest rate swap derivative liabilities is adjusted to reflect the impact of our credit quality. As of September 30, 2013, there have been no termination events or events of default related to our interest rate swaps, except for our voluntary termination as discussed above.

XML

Intangibles Assets and Liabilities

9 Months Ended

Sep. 30, 2013

Identified Intangibles, Net [Abstract]

Intangibles Assets and Liabilities

Intangible Assets and Liabilities

Intangible assets and liabilities consisted of the following as of September 30, 2013 and December 31, 2012 (in thousands, except weighted average remaining amortization period):

	September 30, 2013				December 31, 2012
	Balance			Weighted Average Remaining Amortization Period in Years	Balance			Weighted Average Remaining Amortization Period in Years	Balance Sheet Classification
Assets:
In place leases	$	197,185		8.7	$	174,615		9.7	Lease intangibles
Tenant relationships	189,616			10.6	178,269			11.6	Lease intangibles
Above market leases	25,878			6.3	25,387			6.9	Other intangibles, net
Below market leasehold interests	29,128			63.9	30,587			69.4	Other intangibles, net
	441,807				408,858
Accumulated amortization	(143,160		)		(125,924		)
Total	$	298,647			$	282,934
Liabilities:
Below market leases	$	13,548		13.0	$	12,823		13.7	Intangible liabilities, net
Above market leasehold interests	3,827			33.3	3,827			34.0	Intangible liabilities, net
	17,375				16,650
Accumulated amortization	(6,113		)		(5,341		)
Total	$	11,262			$	11,309

The following is a summary of the net intangible amortization for the three and nine months ended September 30, 2013 and 2012 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Amortization recorded against rental income related to above or below market leases	$	417	$	470	$	1,298	$	1,185
Rental expense related to above or below market leasehold interests	89		106		278		413
Amortization expense related to in place leases and tenant relationships	9,955		10,705		29,912		32,151

XML

Condensed Consolidated Statements of Changes In Partners' Capital - HTALP (Unaudited) (USD $) In Thousands, unless otherwise specified	Total	General Partner	Limited Partner	Healthcare Trust of America Holdings, LP (HTALP)
Balance as of beginning of period at Dec. 31, 2011		$ 1,567,510	$ 1,417	$ 1,568,927
Balance as of beginning of period (in units) at Dec. 31, 2011		228,491	156
Increase (Decrease) in Partners' Capital [Roll Forward]
Issuance of units under the DRIP (in units)		3,362
Issuances under the DRIP		31,915		31,915
Redemptions of general partner units (in units)		(18,150)
Redemptions of general partner units		(185,278)		(185,278)
Share-based award transactions, net (in units)		679	2,875
Share-based award transactions, net		6,365	5,925	12,290
Distributions		(111,165)	(73)	(111,238)
Net income (loss) attributable to controlling interest	(22,588)	(22,588)	9	(22,579)
Balance as of end of period at Sep. 30, 2012		1,286,759	7,278	1,294,037
Balance as of end of period (in units) at Sep. 30, 2012		214,382	3,031
Balance as of beginning of period at Jun. 30, 2012
Increase (Decrease) in Partners' Capital [Roll Forward]
Net income (loss) attributable to controlling interest	(2,952)			(2,951)
Balance as of end of period at Sep. 30, 2012				1,294,037
Balance as of beginning of period at Dec. 31, 2012		1,254,536	11,663	1,266,199
Balance as of beginning of period (in units) at Dec. 31, 2012		214,652	3,056
Increase (Decrease) in Partners' Capital [Roll Forward]
Issuance of general partner units (in units)		20,707
Issuance of general partner units		228,306		228,306
Redemptions of general partner units (in units)		(28)
Redemptions of general partner units		(287)		(287)
Share-based award transactions, net (in units)		412	(2)
Share-based award transactions, net		1,952	3,177	5,129
Distributions		(98,630)	(1,021)	(99,651)
Net income (loss) attributable to controlling interest	20,199	20,199	384	20,583
Balance as of end of period at Sep. 30, 2013		1,406,076	14,203	1,420,279
Balance as of end of period (in units) at Sep. 30, 2013		235,743	3,054
Balance as of beginning of period at Jun. 30, 2013
Increase (Decrease) in Partners' Capital [Roll Forward]
Net income (loss) attributable to controlling interest	4,823			4,996
Balance as of end of period at Sep. 30, 2013				$ 1,420,279

XML

Stockholders' Equity and Partners' Capital (Details) (USD $)	3 Months Ended	9 Months Ended			3 Months Ended	9 Months Ended					0 Months Ended	9 Months Ended	3 Months Ended		9 Months Ended			0 Months Ended
	Sep. 30, 2012 Restricted Stock	Sep. 30, 2013 Restricted Stock	Sep. 30, 2012 Restricted Stock	Sep. 30, 2013 2006 Incentive Plan	Sep. 30, 2013 General and Administrative Expense Restricted Stock	Sep. 30, 2013 General and Administrative Expense Restricted Stock	Sep. 30, 2012 General and Administrative Expense Restricted Stock	Sep. 30, 2013 Listing Expenses Restricted Stock	Sep. 30, 2012 Listing Expenses Restricted Stock	Sep. 30, 2012 Non Traded REIT Expenses Restricted Stock	Jan. 07, 2013 Common Stock Offering	Sep. 30, 2013 Common Stock Offering	Sep. 30, 2013 Long Term Incentive Program Listing Expenses	Sep. 30, 2012 Long Term Incentive Program Listing Expenses	Sep. 30, 2013 Long Term Incentive Program Listing Expenses	Sep. 30, 2012 Long Term Incentive Program Listing Expenses	Sep. 30, 2013 Long Term Incentive Program Change in Control of Company	Nov. 01, 2013 Subsequent Event Maximum Common Stock Offering
Common Stock Offerings [Abstract]
Maximum amount of common stock authorized											$ 250,000,000							$ 300,000,000.0
Issuance of common stock (in shares)												20,707,113
Average share price												$ 11.24
Long-Term Incentive Program [Abstract]
Number of shares authorized (in shares)				10,000,000
Number of shares available for grant (in shares)				5,096,100
Allocated share-based compensation expense	200,000	2,000,000	6,400,000		500,000	1,400,000	200,000	600,000	4,700,000	1,500,000			0	4,500,000	3,100,000	5,900,000
Nonvested awards, total compensation cost not yet recognized		$ 4,200,000															$ 4,500,000
Contingent units																	450,000
Period for recognition		2 years 3 months 18 days

XML

Debt - Principal Maturity Schedule (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Debt Disclosure [Abstract]
2013	$ 1,722
2014	6,872
2015	73,128
2016	421,578
2017	99,963
Thereafter	522,373
Total	$ 1,125,636	$ 1,034,956

XML

Per Share Data (Tables)

9 Months Ended

Sep. 30, 2013

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following is the reconciliation of the numerator and denominator used in basic and diluted earnings (losses) per share of HTA (in thousands, except per share data):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2013		2012			2013		2012
Numerator:
Income (loss) from continuing operations attributable to controlling interest	$	4,443	$	(3,095	)	$	19,474	$	(22,998	)
Discontinued operations	380		143			725		410
Net income (loss) attributable to controlling interest	$	4,823	$	(2,952	)	$	20,199	$	(22,588	)
Denominator:
Weighted average number of shares outstanding - basic	232,514		218,264			225,132		225,501
Dilutive shares	2,509		—			1,639		—
Weighted average number of shares outstanding - diluted	235,023		218,264			226,771		225,501
Earnings (losses) per share attributable to controlling interest - basic:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Earnings (losses) per share attributable to controlling interest - diluted:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)

XML

Supplemental Cash Flow Information (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Supplemental Disclosure of Cash Flow Information:
Interest paid	$ 27,743	$ 30,681
Income taxes paid	904	840
Investing Activities:
Accrued capital expenditures	2,227	1,508
Note receivable included in the consideration for the acquisition of a building	0	37,264
The following represents the significant increase (decrease) in certain assets and liabilities in connection with our acquisition of operating properties:
Debt	17,982	0
Financing Activities:
Issuances under the DRIP	0	31,915
Dividend distributions declared, but not paid, including under the DRIP	34,238	30,959
Offering costs transferred to equity/partners’ capital	$ 1,192	$ 0

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2013

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Financial Instruments Reported at Fair Value

Derivative Financial Instruments

Currently, we use interest rate swaps to manage interest rate risk associated with variable rate debt. The valuation of these instruments is determined with the assistance of an independent valuation specialist using a proprietary model that utilizes widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative, and observable inputs. As such, we classify these inputs as Level 2. The proprietary model reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates, and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves.

We incorporate credit valuation adjustments to appropriately reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees.

Although we have determined that the majority of the inputs used to value our interest rate swap derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. However, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our interest rate swap derivative positions and have determined that the credit valuation adjustments are not significant to their overall valuation. As a result, we have determined that our interest rate swap derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.

Assets and Liabilities at Fair Value

The table below presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2013, aggregated by the level in the fair value hierarchy (in thousands):

	Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1 )		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets:
Derivative financial instruments	$	—	$	3,656	$	—	$	3,656
Total assets at fair value	$	—	$	3,656	$	—	$	3,656
Liabilities:
Derivative financial instruments	$	—	$	3,258	$	—	$	3,258
Total liabilities at fair value	$	—	$	3,258	$	—	$	3,258

The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2012, aggregated by the level in the fair value hierarchy (in thousands):

	Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1 )		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets:
Derivative financial instruments	$	—	$	—	$	—	$	—
Total assets at fair value	$	—	$	—	$	—	$	—
Liabilities:
Derivative financial instruments	$	—	$	9,370	$	—	$	9,370
Total liabilities at fair value	$	—	$	9,370	$	—	$	9,370

There have been no transfers of assets or liabilities between levels. We will record any such transfers at the end of the reporting period in which a change of event occurs that results in a transfer.

Financial Instruments Disclosed at Fair Value

We consider the carrying values of cash and cash equivalents, accounts and other receivables (net), restricted cash and escrow deposits, and accounts payable and accrued liabilities to approximate fair value for these financial instruments because of the short period of time between origination of the instruments and their expected realization. All of these financial instruments are considered Level 2. The following table sets forth the carrying value and fair value of our real estate notes receivable, tenant note receivable and debt (net) (in thousands):

		September 30, 2013				December 31, 2012
	Fair Value Level	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Real estate notes receivable	2	$	28,520	$	28,520	$	20,000	$	20,000
Tenant note receivable	2	3,202		3,098		3,287		3,337
Debt, net	2	1,125,792		1,149,460		1,037,359		1,087,168

XML

Debt

9 Months Ended

Sep. 30, 2013

Debt Disclosure [Abstract]

Debt

Debt

Debt consisted of the following as of September 30, 2013 and December 31, 2012 (in thousands):

	September 30, 2013		December 31, 2012
Unsecured revolving credit facility	$	—	$	72,000
Unsecured term loans	455,000		455,000
Unsecured senior notes	300,000		—
Fixed rate mortgages	370,636		382,456
Secured real estate term loan	—		125,500
	1,125,636		1,034,956
Net premium	156		2,403
Total	$	1,125,792	$	1,037,359

Unsecured Credit Agreement

On March 29, 2012, we entered into an unsecured credit agreement to obtain a $575.0 million unsecured revolving credit facility and a $300.0 million unsecured term loan. On March 7, 2013, we executed an amendment to the unsecured credit agreement pursuant to an existing provision therein to increase the principal amount of the unsecured revolving credit facility. This amendment added an additional lender and increased the unsecured revolving credit facility by $75.0 million to $650.0 million. The other existing terms of the unsecured credit agreement were unchanged. The unsecured credit agreement matures on March 29, 2016 and includes a one-year extension option, subject to certain conditions.

The actual amount of credit available under our unsecured credit agreement is a function of certain loan-to-value and debt service coverage ratios. The maximum principal amount may be increased; subject to such additional financing being provided by our existing lenders or new lenders added to the unsecured revolving credit facility.

Borrowings under the $650.0 million unsecured revolving credit facility accrue interest equal to adjusted LIBOR plus a margin ranging from 1.10% to 1.75% per annum based on our credit rating. We also pay a facility fee ranging from 0.20% to 0.50% per annum on the aggregate commitments under the unsecured revolving credit facility. As of September 30, 2013, the margin associated with borrowings was 1.55% per annum and the facility fee was 0.35% per annum. As of September 30, 2013, no amount was outstanding on our unsecured revolving credit facility.

Borrowings under the $300.0 million unsecured term loan accrue interest equal to adjusted LIBOR plus a margin ranging from 1.30% to 2.25% per annum based on our credit rating. The margin associated with borrowings as of September 30, 2013 was 1.85% per annum. We have interest rate swaps in place that fix the interest rate at 2.95% per annum, based on our current credit rating.

$155.0 million Unsecured Term Loan

On July 20, 2012, we entered into a $155.0 million unsecured term loan that matures on July 19, 2019. The interest rate thereon is equal to LIBOR plus a margin ranging from 1.55% to 2.40% per annum based on our credit rating. The margin associated with the borrowings as of September 30, 2013 was 2.00% per annum. We have interest rate swaps in place that fix the interest rate at 3.29% per annum, based on our current credit rating. The maximum principal amount may be increased by us, subject to such additional financing being provided by our existing lender.

$300.0 million Unsecured Senior Notes

On March 28, 2013, we issued $300.0 million of unsecured senior notes that mature on April 15, 2023. The unsecured senior notes bear interest at 3.70% per annum payable semi-annually and were offered at 99.186% of the principal amount thereof. The unsecured senior notes include registration rights to the holders, pursuant to which we filed an exchange offer on Form S-4 on October 22, 2013.

Fixed Rate Mortgages

As of September 30, 2013, we had fixed rate mortgages with interest rates ranging from 4.55% to 12.75% per annum and a weighted average interest rate of 5.86% per annum. As part of an acquisition, we assumed two mortgage loans; see Note 3, Business Combinations.

Secured Real Estate Term Loan

On March 28, 2013, we repaid in full the $125.5 million secured real estate term loan. In connection with that repayment, we terminated the secured real estate term loan (and the commitments thereunder) and the related security documents and guarantees. In addition, we terminated the $75.0 million interest rate swap associated with the secured real estate term loan.

Future Debt Maturities

As of September 30, 2013, the principal payments due on our debt for the three months ending December 31, 2013, for each of the next four years ending December 31 and thereafter, is as follows (in thousands):

Year	Amount
2013	$	1,722
2014	6,872
2015	73,128
2016	421,578
2017	99,963
Thereafter	522,373
Total	$	1,125,636

The above scheduled debt maturities do not include the available extension under the unsecured credit agreement as discussed above.

We are required by the terms of our applicable credit agreements to meet various affirmative and negative covenants that we believe are customary for these types of facilities, such as limitations on the incurrence of debt by us, and our subsidiaries that own unencumbered assets, limitations on the nature of HTALP’s business, and limitations on distributions by HTALP and its subsidiaries that own unencumbered assets. Our credit agreements also impose various financial covenants on us, such as a maximum ratio of total indebtedness to total asset value, a minimum ratio of EBITDA to fixed charges, a minimum tangible net worth covenant, a maximum ratio of unsecured indebtedness to unencumbered asset value, rent coverage ratios, and a minimum ratio of unencumbered net operating income to unsecured interest expense. As of September 30, 2013, we believe that we were in compliance with all such financial covenants and reporting requirements. In addition, certain of our credit agreements include events of default provisions that we believe are customary for these types of facilities, including restricting HTA from making dividend distributions to our stockholders in the event we are in default, except to the extent necessary for HTA to maintain its REIT status.

XML

Supplemental Cash Flow Information

9 Months Ended

Sep. 30, 2013

Supplemental Cash Flow Elements [Abstract]

Supplemental Cash Flow Information

Supplemental Cash Flow Information

The following is the supplemental cash flow information for the nine months ended September 30, 2013 and 2012 (in thousands):

	Nine Months Ended September 30,
	2013		2012
Interest paid	$	27,743	$	30,681
Income taxes paid	904		840
Supplemental Disclosure of Noncash Activities:
Investing Activities:
Accrued capital expenditures	$	2,227	$	1,508
Note receivable included in the consideration for the acquisition of a building	—		37,264
The following represents the significant increase (decrease) in certain assets and liabilities in connection with our acquisition of operating properties:
Debt	$	17,982	$	—
Financing Activities:
Issuances under the DRIP	$	—	$	31,915
Dividend distributions declared, but not paid, including under the DRIP	34,238		30,959
Offering costs transferred to equity/partners’ capital	1,192		—

XML

Per Share Data

9 Months Ended

Sep. 30, 2013

Earnings Per Share [Abstract]

Per Share Data

Per Share Data

We include unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents as “participating securities” pursuant to the two-class method. The resulting classes are our common stock and restricted stock. For the three and nine months ended September 30, 2013 and 2012, all of our earnings were distributed and the calculated earnings (losses) per share amount would be the same for all classes.

For the three and nine months ended September 30, 2012, approximately 156,000 shares of HTA were excluded from the computation of diluted shares as their impact would have been anti-dilutive. The following is the reconciliation of the numerator and denominator used in basic and diluted earnings (losses) per share of HTA (in thousands, except per share data):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2013		2012			2013		2012
Numerator:
Income (loss) from continuing operations attributable to controlling interest	$	4,443	$	(3,095	)	$	19,474	$	(22,998	)
Discontinued operations	380		143			725		410
Net income (loss) attributable to controlling interest	$	4,823	$	(2,952	)	$	20,199	$	(22,588	)
Denominator:
Weighted average number of shares outstanding - basic	232,514		218,264			225,132		225,501
Dilutive shares	2,509		—			1,639		—
Weighted average number of shares outstanding - diluted	235,023		218,264			226,771		225,501
Earnings (losses) per share attributable to controlling interest - basic:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Earnings (losses) per share attributable to controlling interest - diluted:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)

XML

Document and Entity Information	9 Months Ended			9 Months Ended
	Sep. 30, 2013	Oct. 31, 2013 Class A	Oct. 31, 2013 Class B	Sep. 30, 2013 Healthcare Trust of America Holdings, LP (HTALP)
Entity Information [Line Items]
Entity Registrant Name	HEALTHCARE TRUST OF AMERICA, INC.			Healthcare Trust of America Holdings, LP
Entity Central Index Key	0001360604			0001495491
Document Type	10-Q			10-Q
Document Period End Date	Sep. 30, 2013			Sep. 30, 2013
Amendment Flag	false			false
Document Fiscal Year Focus	2013			2013
Document Fiscal Period Focus	Q3			Q3
Current Fiscal Year End Date	--12-31			--12-31
Entity Filer Category	Accelerated Filer			Non-accelerated Filer
Entity Common Stock, Shares Outstanding		179,640,980	57,268,109

XML

Per Unit Data

9 Months Ended

Sep. 30, 2013

Earnings Per Share [Abstract]

Per Unit Data

Per Unit Data

The following is the reconciliation of the numerator and denominator used in basic and diluted earnings (losses) per unit of HTALP (in thousands, except per unit data):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2013		2012			2013		2012
Numerator:
Income (loss) from continuing operations attributable to controlling interest	$	4,616	$	(3,094	)	$	19,858	$	(22,989	)
Discontinued operations	380		143			725		410
Net income (loss) attributable to controlling interest	$	4,996	$	(2,951	)	$	20,583	$	(22,579	)
Denominator:
Weighted average number of units outstanding - basic	235,570		221,413			228,188		227,105
Dilutive units	—		—			—		—
Weighted average number of units outstanding - diluted	235,570		221,413			228,188		227,105
Earnings (losses) per unit attributable to controlling interest - basic:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Earnings (losses) per unit attributable to controlling interest - diluted:
Continuing operations	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)
Discontinued operations	0.00		0.00			0.00		0.00
Net income (loss)	$	0.02	$	(0.01	)	$	0.09	$	(0.10	)